Snowflake (SNOW) 10-Q 3 Dec 21 2022 Q3 Quarterly report Financial data

Cover

Cover - shares shares in Millions	9 Months Ended
	Oct. 31, 2021	Nov. 19, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2021
Document Transition Report	false
Entity File Number	001-39504
Entity Registrant Name	SNOWFLAKE INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	46-0636374
Entity Address, Address Line One	Suite 3A
Entity Address, Address Line Two	106 East Babcock Street
Entity Address, City or Town	Bozeman
Entity Address, State or Province	MT
Entity Address, Postal Zip Code	59715
City Area Code	844
Local Phone Number	766-9355
Title of 12(b) Security	Class A Common Stock, $0.0001 par value
Trading Symbol	SNOW
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		306.3
Entity Central Index Key	0001640147
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Oct. 31, 2021	Jan. 31, 2021
Current assets:
Cash and cash equivalents		$ 935,217	$ 820,177
Short-term investments		2,955,613	3,087,887
Accounts receivable, net		254,243	294,017
Deferred commissions, current		42,896	32,371
Prepaid expenses and other current assets		120,288	66,200
Total current assets		4,308,257	4,300,652
Long-term investments		1,211,858	1,165,275
Property and equipment, net		94,377	68,968
Operating lease right-of-use assets		184,057	186,818
Goodwill		8,449	8,449
Intangible assets, net		26,167	16,091
Deferred commissions, non-current		101,551	86,164
Other assets		228,755	89,322
Total assets		6,163,471	5,921,739
Current liabilities:
Accounts payable		10,559	5,647
Accrued expenses and other current liabilities		163,238	125,315
Operating lease liabilities, current		25,194	19,650
Deferred revenue, current		759,744	638,652
Total current liabilities		958,735	789,264
Operating lease liabilities, non-current		178,697	184,887
Deferred revenue, non-current		7,132	4,194
Other liabilities		12,225	6,923
Total liabilities		1,156,789	985,268
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred stock; $0.0001 par value per share; 200,000,000 shares authorized as of October 31, 2021 and January 31, 2021; zero shares issued and outstanding as of October 31, 2021 and January 31, 2021		0	0
Additional paid-in capital		6,797,354	6,175,425
Accumulated other comprehensive income (loss)		(3,486)	439
Accumulated deficit		(1,787,216)	(1,239,421)
Total stockholders’ equity		5,006,682	4,936,471
Total liabilities and stockholders’ equity		6,163,471	5,921,739
Class A Common Stock
Stockholders’ equity:
Common stock	[1]	30	11
Class B Common Stock
Stockholders’ equity:
Common stock	[1]	$ 0	$ 17
[1]	On March 1, 2021, all shares of the Company’s then-outstanding Class B common stock were automatically converted into the same number of shares of Class A common stock, pursuant to the terms of the Company’s amended and restated certificate of incorporation. No additional shares of Class B common stock will be issued following such conversion. See Note 11 for further details.

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - $ / shares	Oct. 31, 2021	Jan. 31, 2021
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	200,000,000	200,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	2,500,000,000	2,500,000,000
Common stock, shares issued (in shares)	305,899,486	111,374,416
Common stock, shares outstanding (in shares)	305,899,486	111,374,416
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	185,461,432	355,000,000
Common stock, shares issued (in shares)	0	176,543,188
Common stock, shares outstanding (in shares)	0	176,543,188

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Income Statement [Abstract]
Revenue		$ 334,441	$ 159,624	$ 835,553	$ 401,584
Cost of revenue		120,786	66,681	324,253	159,684
Gross profit		213,655	92,943	511,300	241,900
Operating expenses:
Sales and marketing		190,971	134,727	540,678	325,267
Research and development		115,900	74,138	343,783	143,949
General and administrative		64,055	53,532	189,846	116,224
Total operating expenses		370,926	262,397	1,074,307	585,440
Operating loss		(157,271)	(169,454)	(563,007)	(343,540)
Interest income		1,985	1,517	6,787	5,654
Other income (expense), net		1,609	(519)	9,867	(1,561)
Loss before income taxes		(153,677)	(168,456)	(546,353)	(339,447)
Provision for income taxes		1,179	433	1,442	720
Net loss		$ (154,856)	$ (168,889)	$ (547,795)	$ (340,167)
Net loss per share attributable to Class A and Class B common stockholders - basic (in dollars per share)	[1]	$ (0.51)	$ (1.01)	$ (1.84)	$ (3.63)
Net loss per share attributable to Class A and Class B common stockholders - diluted (in dollars per share)	[1]	$ (0.51)	$ (1.01)	$ (1.84)	$ (3.63)
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders - basic (in shares)	[1]	303,006,685	166,868,200	297,435,637	93,763,599
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders - diluted (in shares)	[1]	303,006,685	166,868,200	297,435,637	93,763,599
[1]	On March 1, 2021, all shares of the Company’s then-outstanding Class B common stock were automatically converted into the same number of shares of Class A common stock, pursuant to the terms of the Company’s amended and restated certificate of incorporation. No additional shares of Class B common stock will be issued following such conversion. See Note 11 for further details.

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Statement of Comprehensive Income [Abstract]
Net loss	$ (154,856)	$ (168,889)	$ (547,795)	$ (340,167)
Other comprehensive income (loss):
Foreign currency translation adjustments	(361)	0	(63)	0
Net change in unrealized gains or losses on available-for-sale securities	(4,266)	(771)	(3,862)	159
Total other comprehensive income (loss)	(4,627)	(771)	(3,925)	159
Comprehensive loss	$ (159,483)	$ (169,660)	$ (551,720)	$ (340,008)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands		Total	Common Stock		Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2020		169,921,272
Beginning balance at Jan. 31, 2020		$ 936,474
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of redeemable convertible preferred stock (in shares)		12,349,827
Issuance of redeemable convertible preferred stock		$ 478,573
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)		(182,271,099)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering		$ (1,415,047)
Ending balance (in shares) at Oct. 31, 2020		0
Ending balance at Oct. 31, 2020		$ 0
Beginning balance (in shares) at Jan. 31, 2020			55,452,421
Beginning balance at Jan. 31, 2020		(544,757)	$ 6		$ 155,340	$ 216	$ (700,319)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)			182,271,099
Conversion of redeemable convertible preferred stock to common stock upon initial public offering		1,415,047	$ 18		1,415,029
Issuance of common stock upon initial public offering and private placements, net of underwriting discounts (in shares)			36,366,666
Issuance of common stock upon initial public offering and private placements, net of underwriting discounts		4,242,284	$ 4		4,242,280
Issuance of common stock upon exercise of stock options (in shares)			9,031,461
Issuance of common stock upon exercise of stock options		31,098			31,098
Exercise of common stock warrants (in shares)			32,241
Repurchase of early exercised stock options (in shares)			(40,000)
Vesting of early exercised stock options and restricted common stock		5,341			5,341
Vesting of restricted stock units (in shares)			5,657
Stock-based compensation		158,810			158,810
Other comprehensive income (loss)		159				159
Net loss		(340,167)					(340,167)
Ending balance (in shares) at Oct. 31, 2020			283,119,545
Ending balance at Oct. 31, 2020		$ 4,967,815	$ 28		6,007,898	375	(1,040,486)
Beginning balance (in shares) at Jul. 31, 2020		182,271,099
Beginning balance at Jul. 31, 2020		$ 1,415,047
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)		(182,271,099)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering		$ (1,415,047)
Ending balance (in shares) at Oct. 31, 2020		0
Ending balance at Oct. 31, 2020		$ 0
Beginning balance (in shares) at Jul. 31, 2020			62,257,063
Beginning balance at Jul. 31, 2020		(651,399)	$ 6		219,046	1,146	(871,597)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)			182,271,099
Conversion of redeemable convertible preferred stock to common stock upon initial public offering		1,415,047	$ 18		1,415,029
Issuance of common stock upon initial public offering and private placements, net of underwriting discounts (in shares)			36,366,666
Issuance of common stock upon initial public offering and private placements, net of underwriting discounts		4,242,284	$ 4		4,242,280
Issuance of common stock upon exercise of stock options (in shares)			2,186,819
Issuance of common stock upon exercise of stock options		10,362			10,362
Exercise of common stock warrants (in shares)			32,241
Vesting of early exercised stock options and restricted common stock		1,756			1,756
Vesting of restricted stock units (in shares)			5,657
Stock-based compensation		119,425			119,425
Other comprehensive income (loss)		(771)				(771)
Net loss		(168,889)					(168,889)
Ending balance (in shares) at Oct. 31, 2020			283,119,545
Ending balance at Oct. 31, 2020		$ 4,967,815	$ 28		6,007,898	375	(1,040,486)
Beginning balance (in shares) at Jan. 31, 2021		0
Beginning balance at Jan. 31, 2021		$ 0
Ending balance (in shares) at Oct. 31, 2021		0
Ending balance at Oct. 31, 2021		$ 0
Beginning balance (in shares) at Jan. 31, 2021	[1]		287,917,604
Beginning balance at Jan. 31, 2021		4,936,471	$ 28	[1]	6,175,425	439	(1,239,421)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	[1]		15,278,682
Issuance of common stock upon exercise of stock options		90,376	$ 2	[1]	90,374
Issuance of common stock under employee stock purchase plan (in shares)	[1]		370,452
Issuance of common stock under employee stock purchase plan		52,227			52,227
Vesting of early exercised stock options and restricted common stock		614			614
Vesting of restricted stock units (in shares)	[1]		2,332,748
Stock-based compensation		478,714			478,714
Other comprehensive income (loss)		(3,925)				(3,925)
Net loss		(547,795)					(547,795)
Ending balance (in shares) at Oct. 31, 2021	[1]		305,899,486
Ending balance at Oct. 31, 2021		$ 5,006,682	$ 30	[1]	6,797,354	(3,486)	(1,787,216)
Beginning balance (in shares) at Jul. 31, 2021		0
Beginning balance at Jul. 31, 2021		$ 0
Ending balance (in shares) at Oct. 31, 2021		0
Ending balance at Oct. 31, 2021		$ 0
Beginning balance (in shares) at Jul. 31, 2021			300,584,903
Beginning balance at Jul. 31, 2021		$ 4,964,965	$ 30		6,596,154	1,141	(1,632,360)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		4,222,037	4,222,037
Issuance of common stock upon exercise of stock options		$ 24,708			24,708
Issuance of common stock under employee stock purchase plan (in shares)			111,645
Issuance of common stock under employee stock purchase plan		25,829			25,829
Vesting of early exercised stock options and restricted common stock		191			191
Vesting of restricted stock units (in shares)			980,901
Stock-based compensation		150,472			150,472
Other comprehensive income (loss)		(4,627)				(4,627)
Net loss		(154,856)					(154,856)
Ending balance (in shares) at Oct. 31, 2021	[1]		305,899,486
Ending balance at Oct. 31, 2021		$ 5,006,682	$ 30	[1]	$ 6,797,354	$ (3,486)	$ (1,787,216)
[1]	On March 1, 2021, all shares of the Company’s then-outstanding Class B common stock were automatically converted into the same number of shares of Class A common stock, pursuant to the terms of the Company’s amended and restated certificate of incorporation. No additional shares of Class B common stock will be issued following such conversion. See Note 11 for further details.

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) (PARENTHETICAL) - Redeemable Convertible Preferred Stock, Series G-1 And G-2 $ in Thousands	9 Months Ended
	Oct. 31, 2020USD ($)$ / shares
Price per share (in dollars per share) | $ / shares	$ 38.77
Issuance costs | $	$ 230

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Cash flows from operating activities:
Net loss	$ (547,795)	$ (340,167)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	15,586	6,611
Non-cash operating lease costs	25,895	24,840
Amortization of deferred commissions	26,824	21,233
Stock-based compensation, net of amounts capitalized	459,392	157,790
Net amortization of premiums on investments	36,938	1,117
Unrealized gains on strategic investments in equity securities	(8,515)	0
Other	2,535	4,073
Changes in operating assets and liabilities, net of effect of business combinations:
Accounts receivable	39,142	9,221
Deferred commissions	(52,892)	(27,261)
Prepaid expenses and other assets	(112,798)	(29,480)
Accounts payable	4,591	(3,806)
Accrued expenses and other liabilities	43,106	22,477
Operating lease liabilities	(24,758)	(23,418)
Deferred revenue	124,030	111,739
Net cash provided by (used in) operating activities	31,281	(65,031)
Cash flows from investing activities:
Purchases of property and equipment	(12,209)	(24,018)
Capitalized internal-use software development costs	(8,612)	(4,014)
Cash paid for business combinations, net of cash acquired	0	(6,035)
Purchases of intangible assets	(11,182)	(6,184)
Purchases of investments	(3,042,396)	(1,235,020)
Sales of investments	407,003	28,705
Maturities and redemptions of investments	2,610,429	371,528
Net cash used in investing activities	(56,967)	(875,038)
Cash flows from financing activities:
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs	0	478,573
Proceeds from initial public offering and private placements, net of underwriting discounts	0	4,242,284
Proceeds from early exercised stock options	0	159
Proceeds from exercise of stock options	90,444	31,100
Proceeds from issuance of common stock under the employee stock purchase plan	52,227	0
Proceeds from repayments of a nonrecourse promissory note	0	2,090
Repurchases of early exercised stock options	0	(30)
Payments of deferred purchase consideration for business combinations	0	(1,164)
Net cash provided by financing activities	142,671	4,753,012
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	21	0
Net increase in cash, cash equivalents, and restricted cash	117,006	3,812,943
Cash, cash equivalents, and restricted cash—beginning of period	835,193	141,976
Cash, cash equivalents, and restricted cash—end of period	952,199	3,954,919
Supplemental disclosures of non-cash investing and financing activities:
Property and equipment included in accounts payable and accrued expenses	3,115	2,803
Stock-based compensation included in capitalized software development costs	18,923	1,020
Vesting of early exercised stock options and restricted common stock	615	3,251
Intangible assets included in accrued expenses and other liabilities	4,544	0
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents	935,217	3,939,925
Restricted cash – included in other assets and prepaid expenses and other current assets	16,982	14,994
Total cash, cash equivalents, and restricted cash	$ 952,199	$ 3,954,919

Organization and Description of

Organization and Description of Business	9 Months Ended
	Oct. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Description of Business Snowflake Inc. (Snowflake or the Company) provides a cloud-based data platform, which enables customers to consolidate data to drive meaningful business insights, build data-driven applications, and share data. The Company provides its platform through a customer-centric, consumption-based business model, only charging customers for the resources they use. Through its platform, the Company delivers the Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from rapidly growing data sets in secure, governed, and compliant ways. Snowflake was incorporated in the state of Delaware on July 23, 2012.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Fiscal Year The Company’s fiscal year ends on January 31. For example, references to fiscal 2022 refer to the fiscal year ending January 31, 2022. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and applicable rules and regulations of the U.S. Securities and Exchange Commission (SEC) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2021, which was filed with the SEC on March 31, 2021. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the Company’s financial position as of October 31, 2021 and the results of operations for the three and nine months ended October 31, 2021 and 2020, and cash flows for the nine months ended October 31, 2021 and 2020. The condensed balance sheet as of January 31, 2021 was derived from the audited financial statements but does not include all disclosures required by GAAP. The results of operations for the three and nine months ended October 31, 2021 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period. Principles of Consolidation The condensed consolidated financial statements include the accounts of Snowflake Inc. and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Segment Information The Company has a single operating and reportable segment. The Company’s chief operating decision maker is its Chief Executive Officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance, and allocating resources. For information regarding the Company’s long-lived assets and revenue by geographic area, see Note 14. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such estimates include, but are not limited to, stand-alone selling prices (SSP) for each distinct performance obligation, internal-use software development costs, expected period of benefit for deferred commissions, the useful lives of long-lived assets, the carrying value of operating lease right-of-use assets, the valuation of the Company’s common stock prior to its initial public offering (IPO) in September 2020, stock-based compensation, accounting for income taxes, and the fair value of investments in marketable and non-marketable securities. The Company bases its estimates on historical experience and also on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates due to risks and uncertainties, including uncertainty in the current economic environment due to the COVID-19 pandemic. Summary of Significant Accounting Policies The Company’s significant accounting policies are discussed in “Note 2 – Basis of Presentation and Summary of Significant Accounting Policies” of the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2021, which was filed with the SEC on March 31, 2021. There have been no significant changes to these policies during the nine months ended October 31, 2021, except for (i) the accounting policies for accounts receivable and investments that were updated below as a result of the Company’s adoption of the Financial Accounting Standards Board (FASB) Accounting Standards Update (ASU) No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , effective February 1, 2021, and (ii) the accounting policy for strategic investments that was updated below with respect to the Company’s strategic investment in marketable equity securities during the three months ended October 31, 2021. Accounts Receivable Accounts receivable includes billed and unbilled receivables, net of allowance for credit losses. Trade accounts receivable are recorded at invoiced amounts and do not bear interest. The allowance for credit losses is estimated based on the Company’s assessment of the collectibility of accounts receivable by considering various factors, including the age of each outstanding invoice, the collection history of each customer, historical write-off experience, current economic conditions, and reasonable and supportable forecasts of future economic conditions over the life of the receivable. The Company assesses collectibility by reviewing accounts receivable on an aggregate basis when similar characteristics exist and on an individual basis when specific customers with collectibility issues are identified. Accounts receivable deemed uncollectible are charged against the allowance for credit losses when identified. Allowance for credit losses was $0.9 million and $2.6 million as of October 31, 2021 and January 31, 2021, respectively. Investments The Company’s investments in marketable debt securities have been classified and accounted for as available-for-sale and are recorded at estimated fair value. The Company classifies its marketable debt securities as either short-term or long-term at each balance sheet date based on each instrument’s underlying contractual maturity date. Short-term investments are investments with original maturities of less than one year when purchased. For available-for-sale debt securities in an unrealized loss position, the Company first assesses whether it intends to sell or it is more likely than not that the Company will be required to sell the security before the recovery of its entire amortized cost basis. If either of these criteria is met, the security’s amortized cost basis is written down to fair value through other income (expense), net in the condensed consolidated statements of operations. If neither of these criteria is met, the Company further assesses whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. Credit related unrealized losses are recognized as an allowance on the condensed consolidated balance sheets with a corresponding charge in the other income (expense), net in the condensed consolidated statements of operations. Non-credit related unrealized losses and unrealized gains on available-for-sale debt securities are included in accumulated other comprehensive income (loss). Realized gains and losses are determined based on the specific identification method and are reported in other income (expense), net in the condensed consolidated statements of operations. Strategic Investments The Company’s strategic investments consist of non-marketable equity and debt securities in privately-held companies and marketable equity securities in publicly-traded companies, in each case in which the Company does not have a controlling interest or significant influence. Strategic investments are included in other assets on the condensed consolidated balance sheets. The Company’s non-marketable equity securities are recorded at cost and adjusted for observable transactions for the same or similar investments of the same issuer (referred to as the Measurement Alternative) or impairment. For these investments, the Company recognizes remeasurement adjustments, including upward and downward adjustments, and impairments, if any, in other income (expense), net in the condensed consolidated statements of operations. Valuations of privately-held securities are inherently complex due to the lack of readily available market data and require the use of judgment. For example, determining whether an orderly transaction is for an identical or similar investment requires judgment based on the rights and obligations that attached to the securities. In determining the estimated fair value of these investments, the Company uses the most recent data available to the Company. Marketable equity securities are measured at fair value with changes in fair value recorded in other income (expense), net in the condensed consolidated statements of operations. Non-marketable debt securities are classified as available-for-sale and are recorded at their estimated fair value with changes in fair value recorded through accumulated other comprehensive income (loss). Strategic investments are subject to periodic impairment analyses, which involve an assessment of both qualitative and quantitative factors, including the investee’s financial metrics, market acceptance of the investee’s product or technology, and the rate at which the investee is using its cash. If the investment is considered impaired, the Company recognizes an impairment through other income (expense), net in the condensed consolidated statements of operations and establishes a new carrying value for the investment. Recently Adopted Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , which requires a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected, with further clarifications made more recently. For trade receivables, loans, and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses, which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are required to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. This guidance is effective for the Company for its fiscal year beginning February 1, 2023 and interim periods within that fiscal year, and requires a cumulative effect adjustment to the balance sheet as of the beginning of the first reporting period in which the guidance is effective. Early adoption is permitted. The Company early adopted this guidance effective February 1, 2021 on a modified retrospective basis, and the adoption did not result in any cumulative effect adjustment in its condensed consolidated financial statements. In August 2018, the FASB issued ASU No. 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract , which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this new guidance. This new guidance is effective for the Company for its fiscal year beginning February 1, 2021 and interim periods within its fiscal year beginning February 1, 2022, and early adoption is permitted. The Company adopted this guidance effective February 1, 2021 on a prospective basis, and the adoption did not have a material impact on its condensed consolidated financial statements . In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes by eliminating some exceptions to the general approach in ASC 740, Income Taxes (ASC 740) in order to reduce the cost and complexity of its application. This new guidance is effective for the Company for its fiscal year beginning February 1, 2022 and interim periods within its fiscal year beginning February 1, 2023, and early adoption is permitted. Most amendments within this guidance are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company early adopted this guidance effective February 1, 2021, and the adoption did not have a material impact on its condensed consolidated financial statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers , as if it had originated the contracts. Under the current business combinations guidance, such assets and liabilities are recognized by the acquirer at fair value on the acquisition date. This new guidance is effective for the Company for its fiscal year beginning February 1, 2023 and interim periods within that fiscal year, and early adoption is permitted. The Company early adopted this guidance upon issuance to all business combinations that occur on or after the date of adoption. The adoption had no impact on the Company’s condensed consolidated financial statements as there were no acquisitions accounted for as business combinations in fiscal 2022.

Cash Equivalents and Investment

Cash Equivalents and Investments	9 Months Ended
	Oct. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Cash Equivalents and Investments	Cash Equivalents and Investments The following is a summary of the Company’s cash equivalents, short-term investments, and long-term investments on the condensed consolidated balance sheets (in thousands): October 31, 2021 Amortized Gross Gross Estimated Cash equivalents: Money market funds $ 581,689 $ — $ — $ 581,689 U.S. government securities 60,000 — — 60,000 Commercial paper 46,992 1 — 46,993 Certificates of deposit 27,001 1 — 27,002 Corporate notes and bonds 6,193 1 (1) 6,193 Total cash equivalents 721,875 3 (1) 721,877 Investments: Corporate notes and bonds 2,512,863 192 (3,278) 2,509,777 Commercial paper 1,066,027 82 (131) 1,065,978 U.S. government and agency securities 391,632 25 (321) 391,336 Certificates of deposit 200,382 31 (33) 200,380 Total investments 4,170,904 330 (3,763) 4,167,471 Total cash equivalents and investments $ 4,892,779 $ 333 $ (3,764) $ 4,889,348 January 31, 2021 Amortized Gross Gross Estimated Cash equivalents: Money market funds $ 334,891 $ — $ — $ 334,891 Commercial paper 242,040 2 (5) 242,037 Corporate notes and bonds 58,969 3 (2) 58,970 U.S. government securities 23,700 — — 23,700 Certificates of deposit 23,500 3 — 23,503 Total cash equivalents 683,100 8 (7) 683,101 Investments: Corporate notes and bonds 2,287,006 628 (481) 2,287,153 U.S. government and agency securities 1,016,059 250 (46) 1,016,263 Commercial paper 711,389 85 (102) 711,372 Certificates of deposit 238,278 97 (1) 238,374 Total investments 4,252,732 1,060 (630) 4,253,162 Total cash equivalents and investments $ 4,935,832 $ 1,068 $ (637) $ 4,936,263 As of October 31, 2021, the contractual maturities of the Company’s available-for-sale marketable debt securities did not exceed 36 months. The estimated fair values of available-for-sale debt securities, by remaining contractual maturity, are as follows (in thousands): October 31, 2021 Estimated Due within 1 year $ 3,095,801 Due in 1 year to 3 years 1,211,858 Total $ 4,307,659 The following table shows the fair values and the gross unrealized losses of these securities, classified by the length of time that the securities have been in a continuous unrealized loss position, and aggregated by investment types, excluding those securities classified within cash and cash equivalents on the condensed consolidated balance sheets (in thousands): October 31, 2021 Less than 12 Months 12 Months or Greater Total Fair Value Gross Fair Value Gross Fair Value Gross Cash equivalents: Commercial paper $ 17,998 $ — $ — $ — $ 17,998 $ — Corporate notes and bonds 5,058 (1) — — 5,058 (1) Total cash equivalents 23,056 (1) — — 23,056 (1) Investments: Corporate notes and bonds 2,170,442 (3,278) — — 2,170,442 (3,278) Commercial paper 449,901 (131) — — 449,901 (131) U.S. government and agency securities 230,705 (321) — — 230,705 (321) Certificates of deposit 40,844 (33) — — 40,844 (33) Total investments 2,891,892 (3,763) — — 2,891,892 (3,763) Total cash equivalents and investments $ 2,914,948 $ (3,764) $ — $ — $ 2,914,948 $ (3,764) Gross unrealized losses on the Company’s available-for-sale marketable debt securities were $0.6 million as of January 31, 2021. For available-for-sale marketable debt securities with unrealized loss positions, the Company does not intend to sell these securities and it is more likely than not that the Company will hold these securities until maturity or a recovery of the cost basis. The decline in fair value of these securities due to credit related factors was not material as of October 31, 2021 or January 31, 2021. See Note 4 for information regarding the Company’s strategic investments.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company accounts for certain of its financial assets at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows: Level 1 Inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. Level 2 Inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. Level 3 Inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. The following table presents the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis as of October 31, 2021 (in thousands): Level 1 Level 2 Total Cash equivalents: Money market funds $ 581,689 $ — $ 581,689 U.S. government securities — 60,000 60,000 Commercial paper — 46,993 46,993 Certificates of deposit — 27,002 27,002 Corporate notes and bonds — 6,193 6,193 Short-term investments: Corporate notes and bonds — 1,454,923 1,454,923 Commercial paper — 1,065,978 1,065,978 U.S. government and agency securities — 243,323 243,323 Certificates of deposit — 191,389 191,389 Long-term investments: Corporate notes and bonds — 1,054,854 1,054,854 U.S. government and agency securities — 148,013 148,013 Certificates of deposit — 8,991 8,991 Total $ 581,689 $ 4,307,659 $ 4,889,348 The following table presents the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis as of January 31, 2021 (in thousands): Level 1 Level 2 Total Cash equivalents: Money market funds $ 334,891 $ — $ 334,891 Commercial paper — 242,037 242,037 Corporate notes and bonds — 58,970 58,970 U.S. government securities — 23,700 23,700 Certificates of deposit — 23,503 23,503 Short-term investments: Corporate notes and bonds — 1,318,573 1,318,573 U.S. government and agency securities — 829,318 829,318 Commercial paper — 711,372 711,372 Certificates of deposit — 228,624 228,624 Long-term investments: Corporate notes and bonds — 968,580 968,580 U.S. government and agency securities — 186,945 186,945 Certificates of deposit — 9,750 9,750 Total $ 334,891 $ 4,601,372 $ 4,936,263 The Company determines the fair value of its security holdings based on pricing from the Company’s service providers and market prices from industry-standard independent data providers. Such market prices may be quoted prices in active markets for identical assets (Level 1 inputs) or pricing determined using inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs), such as yield curve, volatility factors, credit spreads, default rates, loss severity, current market and contractual prices for the underlying instruments or debt, broker and dealer quotes, as well as other relevant economic measures. Strategic Investments The table above does not include the Company’s strategic investments in non-marketable equity securities, which are recorded at fair value on a non-recurring basis using the Measurement Alternative, or the Company's strategic investments in marketable equity securities and non-marketable debt securities, which are recorded at fair value on a recurring basis. The non-marketable equity and debt securities that the Company holds are valued using significant unobservable inputs or data in an inactive market. As a result, the Company classifies these assets as Level 3 within the fair value hierarchy. The estimation of fair value for the Company’s non-marketable equity securities requires the use of an observable transaction price and other unobservable inputs, including the volatility, rights, and obligations of the securities the Company holds. The marketable equity securities that the Company holds are valued using the quoted market price and are classified as Level 1 within the fair value hierarchy. The following table presents the fair value hierarchy for the Company’s strategic investments measured at fair value as of October 31, 2021 (in thousands): Level 1 Level 3 Total Equity securities: Non-marketable equity securities $ — $ 101,951 $ 101,951 Marketable equity securities 20,455 — 20,455 Debt securities: Non-marketable debt securities — 2,250 2,250 Total strategic investments $ 20,455 $ 104,201 $ 124,656 The following table presents the fair value hierarchy for the Company’s strategic investments measured at fair value as of January 31, 2021 (in thousands): Level 1 Level 3 Total Non-marketable equity securities $ — $ 41,000 $ 41,000 Non-marketable debt securities — 500 500 Total strategic investments $ — $ 41,500 $ 41,500 The cumulative amount of upward adjustments recognized on the Company’s strategic investments in non-marketable equity securities was $8.1 million, all of which was recorded during the three months ended July 31, 2021. During the three and nine months ended October 31, 2021, the Company made a strategic investment of $20.0 million in marketable equity securities and recognized an unrealized gain of $0.5 million on this investment.

Property and Equipment, Net

Property and Equipment, Net	9 Months Ended
	Oct. 31, 2021
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): October 31, 2021 January 31, 2021 Computers, equipment, and software $ 6,642 $ 3,817 Furniture and fixtures 8,051 6,627 Leasehold improvements 51,670 41,593 Capitalized internal-use software development costs 16,030 12,855 Construction in progress 31,736 16,030 Total property and equipment 114,129 80,922 Less: accumulated depreciation and amortization (1) (19,752) (11,954) Total property and equipment, net $ 94,377 $ 68,968 ________________ (1) Includes $8.6 million and $5.5 million of accumulated amortization related to capitalized internal-use software development costs as of October 31, 2021 and January 31, 2021, respectively. Depreciation and amortization expense was $3.6 million and $9.9 million for the three and nine months ended October 31, 2021, respectively, and $2.0 million and $4.8 million for the three and nine months ended October 31, 2020, respectively.

Intangible Assets and Goodwill

Intangible Assets and Goodwill	9 Months Ended
	Oct. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	Intangible Assets and Goodwill Intangible Assets Intangible assets, net consisted of the following (in thousands): October 31, 2021 January 31, 2021 Finite-lived intangible assets Assembled workforce $ 15,099 $ — Developed technology 11,332 11,332 Patents 8,174 7,948 Other 47 47 Total finite-lived intangible assets 34,652 19,327 Less: accumulated amortization (9,311) (3,662) Total finite-lived intangible assets, net 25,341 15,665 Infinite-lived intangible assets - trademarks 826 426 Total intangible assets, net $ 26,167 $ 16,091 During the nine months ended October 31, 2021, the Company acquired $15.1 million of assembled workforce assets with a useful life of four years, $0.4 million of infinite-lived trademark intangible assets, and $0.2 million of patents with a useful life of four years. Amortization expense of intangible assets was $1.9 million and $5.7 million for the three and nine months ended October 31, 2021, respectively, and $0.9 million and $1.9 million for the three and nine months ended October 31, 2020, respectively. As of October 31, 2021, future amortization expense is expected to be as follows (in thousands): Amount Fiscal Year Ending January 31, Remainder of 2022 $ 1,922 2023 7,687 2024 7,687 2025 6,838 2026 1,207 Total $ 25,341 Goodwill As of October 31, 2021 and January 31, 2021, goodwill was $8.4 million. No goodwill impairments were recorded for each of the three and nine months ended October 31, 2021 and 2020.

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	9 Months Ended
	Oct. 31, 2021
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): October 31, 2021 January 31, 2021 Accrued compensation $ 82,238 $ 62,451 Accrued third-party cloud infrastructure expenses 13,977 6,648 Employee contributions under employee stock purchase plan 11,252 22,068 Employee payroll tax withheld on employee stock transactions 10,222 1,340 Accrued professional services 8,199 6,628 Accrued taxes 6,850 4,498 Accrued purchases of property and equipment 2,550 6,718 Other 27,950 14,964 Total accrued expenses and other current liabilities $ 163,238 $ 125,315

Deferred Revenue and Remaining

Deferred Revenue and Remaining Performance Obligations	9 Months Ended
	Oct. 31, 2021
Revenue from Contract with Customer [Abstract]
Deferred Revenue and Remaining Performance Obligations	Deferred Revenue and Remaining Performance Obligations Revenue recognized for the three months ended October 31, 2021 from amounts included in deferred revenue as of July 31, 2021 was $255.0 million. Revenue recognized for the three months ended October 31, 2020 from amounts included in deferred revenue as of July 31, 2020 was $121.2 million. Revenue recognized for the nine months ended October 31, 2021 from amounts included in deferred revenue as of January 31, 2021 was $464.0 million. Revenue recognized for the nine months ended October 31, 2020 from amounts included in deferred revenue as of January 31, 2020 was $222.0 million. Remaining performance obligations (RPO) represent the amount of contracted future revenue that has not yet been recognized, including both deferred revenue and non-cancelable contracted amounts that will be invoiced and recognized as revenue in future periods. The Company’s RPO excludes performance obligations from on-demand arrangements as there are no minimum purchase commitments associated with these arrangements, and certain time and materials contracts that are billed in arrears. As of October 31, 2021, the Company’s RPO was $1.8 billion, of which approximately 75% was related to contracts with original terms that exceed one year. The weighted-average remaining life of the Company’s contracts with original terms that exceed one year was 2.4 years as of October 31, 2021. However, the amount and timing of revenue recognition are generally driven by customer consumption, which can extend beyond the original contract term in cases where customers are permitted to roll over unused capacity to future periods, generally upon the purchase of additional capacity at renewal.

Commitment and Contingencies

Commitment and Contingencies	9 Months Ended
	Oct. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Operating Leases The Company leases its facilities for office space under non-cancelable operating leases with various expiration dates through fiscal 2033. Certain lease agreements include options to renew or terminate the lease, which are not reasonably certain to be exercised and therefore are not factored into the determination of lease payments. In addition, the Company subleases certain of its unoccupied facilities to third parties with various expiration dates through fiscal 2030. Such subleases have all been classified as operating leases. Sublease income is recorded as a reduction to the Company’s operating lease costs. Sublease income was $3.4 million and $9.8 million for the three and nine months ended October 31, 2021, respectively, and $3.2 million and $9.6 million for the three and nine months ended October 31, 2020, respectively. Other Contractual Commitments Other contractual commitments relate mainly to third-party cloud infrastructure agreements and subscription arrangements used to facilitate the Company’s operations at the enterprise level. There were no material contractual obligations that were entered into during the nine months ended October 31, 2021 that were outside the ordinary course of business. 401(k) Plan —The Company sponsors a 401(k) defined contribution plan covering all eligible U.S. employees. Contributions to the 401(k) plan are discretionary. The Company did not make any matching contributions to the 401(k) plan for each of the three and nine months ended October 31, 2021 and 2020. Legal Matters —The Company is involved from time to time in various claims and legal actions arising in the ordinary course of business. While it is not feasible to predict or determine the ultimate outcome of these matters, the Company believes that none of its current legal proceedings will have a material adverse effect on its financial position, results of operations, or cash flows for each of the three and nine months ended October 31, 2021 and 2020. Letters of Credit —As of October 31, 2021, the Company had a total of $17.0 million in cash collateralized letters of credit outstanding, substantially in favor of certain landlords for the Company’s leased facilities. These letters of credit renew annually and expire at various dates through fiscal 2033. Indemnification —The Company enters into indemnification provisions under agreements with other parties in the ordinary course of business, including business partners, investors, contractors, customers, and the Company’s officers, directors, and certain employees. The Company has agreed to indemnify and defend the indemnified party for claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party claims due to the Company’s activities or non-compliance with certain representations and warranties made by the Company. It is not possible to determine the maximum potential loss under these indemnification provisions due to the Company’s limited history of prior indemnification claims and the unique facts and circumstances involved in each particular provision . For each of the three and nine months ended October 31, 2021 and 2020, losses recorded in the condensed consolidated statements of operations in connection with the indemnification provisions were not material.

Redeemable Convertible Preferre

Redeemable Convertible Preferred Stock	9 Months Ended
	Oct. 31, 2021
Temporary Equity Disclosure [Abstract]
Redeemable Convertible Preferred Stock	Redeemable Convertible Preferred StockDuring the nine months ended October 31, 2020, the Company issued 8,480,857 shares of Series G-1 redeemable convertible preferred stock and 3,868,970 shares of Series G-2 redeemable convertible preferred stock, each at a price of $38.77 per share. Upon completion of the IPO in September 2020, all shares of the Company’s redeemable convertible preferred stock outstanding, totaling 182,271,099, were automatically converted into an equivalent number of shares of Class B common stock on one-to-one basis and their carrying value of $1.4 billion was reclassified into stockholders’ equity. As of October 31, 2021 and January 31, 2021, there were no shares of redeemable convertible preferred stock issued and outstanding.

Equity

Equity	9 Months Ended
	Oct. 31, 2021
Share-based Payment Arrangement [Abstract]
Equity	Equity Preferred Stock —In connection with the IPO, the Company’s amended and restated certificate of incorporation became effective, which authorized the issuance of 200,000,000 shares of undesignated preferred stock with a par value of $0.0001 per share and with rights and preferences, including voting rights, designated from time to time by the board of directors. Common Stock and Elimination of Dual-Class Structure —The Company has two classes of common stock authorized: Class A common stock and Class B common stock. In connection with the IPO, the Company’s amended and restated certificate of incorporation authorized the issuance of 2,500,000,000 shares of Class A common stock and 355,000,000 shares of Class B common stock. On March 1, 2021, all 169,538,568 shares of the Company's then-outstanding Class B common stock, par value $0.0001 per share, were automatically converted into the same number of shares of Class A common stock, par value $0.0001 per share, pursuant to the terms of the Company’s amended and restated certificate of incorporation. No additional shares of Class B common stock will be issued following such conversion. The shares of Class A common stock and Class B common stock were identical prior to the conversion, except with respect to voting, converting, and transfer rights. Prior to the conversion, each share of Class B common stock was entitled to cast ten votes per share on any matter submitted to a vote of the Company’s stockholders. As a result of the conversion, all former holders of shares of Class B common stock are now holders of shares of Class A common stock, which is entitled to only one vote per share on all matters subject to a stockholder vote. Class A and Class B common stock are referred to as common stock throughout the notes to the condensed consolidated financial statements, unless otherwise indicated. Holders of common stock are entitled to receive any dividends as may be declared from time to time by the board of directors. Prior to the conversion, shares of Class B common stock were convertible to Class A common stock at any time at the option of the stockholder, and shares of Class B common stock would automatically convert to Class A common stock upon the following: (i) sale or transfer of such share of Class B common stock; (ii) the death of the Class B common stockholder (or nine months after the date of death if the stockholder is one of the Company’s founders); and (iii) on the final conversion date, defined as the earlier to occur following an IPO of (a) the first trading day on or after the date on which the outstanding shares of Class B common stock represented less than 10% of the then outstanding Class A and Class B common stock; (b) September 15, 2027, which is the seventh anniversary of the effectiveness of the registration statement filed in connection with the IPO; or (c) the date specified by a vote of the holders of a majority of the outstanding shares of Class B common stock, voting as a single class. In addition, on March 3, 2021, the Company filed a certificate with the Secretary of State of the State of Delaware effecting the retirement of the shares of Class B common stock that were issued but no longer outstanding following the conversion. Upon the effectiveness of the certificate, the Company’s total number of authorized shares of capital stock was reduced by the retirement of 169,538,568 shares of Class B Common Stock. The Company had reserved shares of common stock for future issuance as follows: October 31, 2021 January 31, 2021 2012 Equity Incentive Plan: Options outstanding 47,781,688 64,574,656 Restricted stock units outstanding 5,034,800 7,520,474 2020 Equity Incentive Plan: Shares available for future grants 45,681,389 32,871,367 Restricted stock units outstanding 5,081,153 1,828,083 2020 Employee Stock Purchase Plan: Shares available for future grants 8,208,724 5,700,000 Total shares of common stock reserved for future issuance 111,787,754 112,494,580 In February 2020, certain third parties unaffiliated with the Company commenced an offer to purchase existing outstanding shares of the Company’s Class B common stock from certain equity holders at a price of $38.77 per share. The Company was not a party to this transaction. The transaction was completed in March 2020, and an aggregate of 8.6 million shares of the Company’s Class B common stock were transferred to these third parties. Equity Incentive Plans —In 2012, the Company’s board of directors approved the adoption of the 2012 Equity Incentive Plan (2012 Plan). The 2012 Plan provides for the grant of stock-based awards to employees, non-employee directors, and other service providers of the Company. The 2012 Plan was terminated in September 2020 in connection with the IPO but continues to govern the terms of outstanding awards that were granted prior to the termination of the 2012 Plan. No further equity awards will be granted under the 2012 Plan. With the establishment of the 2020 Equity Incentive Plan (2020 Plan) as further discussed below, upon the expiration, forfeiture, cancellation, or reacquisition of any shares common stock underlying outstanding stock-based awards granted under the 2012 Plan, an equal number of shares of Class A common stock will become available for grant under the 2020 Plan. On March 1, 2021, all shares of the Company’s then-outstanding Class B common stock were automatically converted into the same number of shares of Class A common stock. As a result of this conversion, options and restricted stock units (RSUs) that were previously denominated in shares of Class B common stock and issued under the 2012 Plan remained unchanged, except that they represent the right to receive shares of Class A common stock. In September 2020, the Company’s board of directors adopted, and its stockholders approved, the 2020 Plan, which became effective in connection with the IPO. The 2020 Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock awards, RSU awards, performance awards and other forms of equity compensation (collectively, equity awards). A total of 34,100,000 shares of the Company’s Class A common stock have been reserved for issuance under the 2020 Plan in addition to (i) any annual automatic evergreen increases in the number of shares of Class A common stock reserved for issuance under the 2020 Plan and (ii) upon the expiration, forfeiture, cancellation, or reacquisition of any shares of Class B common stock underlying outstanding stock awards granted under the 2012 Plan, an equal number of shares of Class A common stock, such number of shares not to exceed 78,816,888. In September 2020, the Company’s board of directors adopted, and its stockholders approved, the 2020 Employee Stock Purchase Plan (2020 ESPP), which became effective in connection with the IPO. The 2020 ESPP authorizes the issuance of shares of common stock pursuant to purchase rights granted to employees. A total of 5,700,000 shares of the Company’s Class A common stock have been reserved for future issuance under the 2020 ESPP, in addition to any annual automatic evergreen increases in the number of shares of Class A common stock reserved for future issuance under the 2020 ESPP. The price at which Class A common stock is purchased under the 2020 ESPP is equal to 85% of the fair market value of a share of the Company’s Class A common stock on the first or last day of the offering period, whichever is lower. Offering periods are generally six months long and begin on March 15 and September 15 of each year, except for the first two offering periods. The initial offering period began on September 15, 2020 and ended on February 26, 2021. The second offering period began on March 1, 2021 and ended on September 14, 2021. Stock Options —Stock options granted under the 2012 Plan and the 2020 Plan (collectively, the Plans) generally vest based on continued service over four years and expire ten years from the date of grant. Certain stock options granted under the 2012 Plan are exercisable at any time following the date of grant and expire ten years from the date of grant. Stock option activity and activity regarding shares available for grant under the Plans during the nine months ended October 31, 2021 is as follows: Shares Number of Options Outstanding Weighted- Weighted-Average Remaining Contractual Life Aggregate Balance—January 31, 2021 32,871,367 64,574,656 $ 7.04 7.7 $ 17,138,896 Shares authorized 14,395,880 — Options exercised — (7,081,859) $ 5.82 Options canceled 608,303 (608,303) $ 4.70 RSUs granted (2,413,881) — RSUs forfeited 112,600 — Balance—April 30, 2021 45,574,269 56,884,494 $ 7.21 7.5 $ 12,763,483 Options exercised — (3,974,786) $ 6.15 Options canceled 659,620 (659,620) $ 8.51 RSUs granted (584,752) — RSUs forfeited 119,507 — Balance—July 31, 2021 45,768,644 52,250,088 $ 7.28 7.3 $ 13,503,560 Options exercised — (4,222,037) $ 5.85 Options canceled 246,363 (246,363) $ 8.56 RSUs granted (561,159) — RSUs forfeited 227,541 — Balance—October 31, 2021 45,681,389 47,781,688 $ 7.40 7.1 $ 16,553,557 Vested and exercisable as of October 31, 2021 24,561,457 $ 6.24 6.7 $ 8,537,609 No options were granted during the nine months ended October 31, 2021 and the weighted-average grant-date fair value of options granted during the nine months ended October 31, 2020 was $22.67. The intrinsic value of options exercised for the nine months ended October 31, 2021 and 2020 was $3.8 billion and $544.5 million, respectively. The aggregate grant-date fair value of options vested for the nine months ended October 31, 2021 and 2020 was $62.7 million and $71.0 million, respectively. Restricted Stock Awards —Restricted stock award activity during the nine months ended October 31, 2021 is as follows: Out of the Plans Number of Shares Weighted-Average Grant Date Unvested Balance—January 31, 2021 741,911 $ 2.11 Vested (90,412) $ 2.10 Unvested Balance—April 30, 2021 651,499 $ 2.11 Vested (90,414) $ 2.10 Unvested Balance—July 31, 2021 561,085 $ 2.11 Vested (90,412) $ 2.10 Unvested Balance—October 31, 2021 470,673 $ 2.11 In December 2017, the Company issued 1,250,000 shares of restricted common stock out of the 2012 Plan to an employee at $1.59 per share, payable by a promissory note. The promissory note accrued interest at the lower of 2.11% per annum or the maximum interest rate on commercial loans permissible by law and was partially secured by the underlying restricted stock. The promissory note was considered nonrecourse from an accounting standpoint, and therefore the note is not reflected in the condensed consolidated balance sheets and condensed consolidated statements of stockholders’ equity (deficit). Rather, the note and the share purchases are accounted for as stock option grants, with the related stock-based compensation measured using the Black-Scholes option-pricing model and recognized over the vesting period of five years. The associated shares are legally outstanding and included in the balance of Class B common stock outstanding in the condensed consolidated financial statements during the periods in which Class B common stock was outstanding and in the balance of Class A common stock outstanding thereafter. None of these shares of restricted common stock were considered vested before the underlying promissory note was repaid. In May and June 2020, the outstanding principal amount and all accrued interest under this promissory note of $2.1 million was repaid, and 312,500 shares of restricted common stock were unvested as of October 31, 2021. In March 2019, in connection with the acquisition of a privately-held company, the Company issued 661,635 shares of restricted common stock out of the 2012 Plan. Of the total shares issued, 215,031 shares vested on the grant date, and the remaining shares vest over four years from the grant date. The related post-acquisition stock-based compensation of $1.1 million is being amortized over the requisite service period of four years in the condensed consolidated statements of operations. As of October 31, 2021, 158,173 shares of these restricted common stock were unvested. Common Stock Subject to Repurchase —Common stock purchased pursuant to an early exercise of stock options is not deemed to be outstanding for accounting purposes until those shares vest. The consideration received for an exercise of an option is considered to be a deposit of the exercise price and the related dollar amount is recorded in other liabilities on the condensed consolidated balance sheets. The shares issued upon the early exercise of these unvested stock option awards, which are reflected as exercises in the stock option activity table above, are considered to be legally issued and outstanding on the date of exercise. Upon termination of service, the Company may repurchase unvested shares acquired through the early exercise of stock options at a price equal to the price per share paid upon the exercise of such options. There were 66,515 and 245,633 shares subject to repurchase as of October 31, 2021 and January 31, 2021, respectively, as a result of early exercised options. As of October 31, 2021 and January 31, 2021, the liabilities for common stock subject to repurchase were $0.5 million and $1.2 million, respectively, which were recorded as other liabilities on the condensed consolidated balance sheets. Modification of Early Exercised Stock Options — In connection with the termination of a former executive officer in April 2019, certain shares of his early exercised stock options were vested immediately. The remaining early exercised stock options held by him were subject to continuous vesting through April 2020 as he continued to provide service to the Company as an advisor. The acceleration and continuation of vesting were accounted for as a modification of the terms of the original award. The incremental stock-based compensation related to this modification was $16.7 million, of which $2.7 million was recognized for the nine months ended October 31, 2020. RSUs —In March 2020, the Company began granting more RSUs than options to its employees and directors. RSUs granted prior to the IPO had both service-based and performance-based vesting conditions. The service-based vesting condition for these awards is typically satisfied over four years with a cliff vesting period of one year and continued vesting quarterly thereafter. The performance-based vesting condition is satisfied on the earlier of (i) the effective date of a registration statement of the Company filed under the Securities Act for the sale of the Company’s common stock or (ii) immediately prior to the closing of a change in control of the Company. Both events were not deemed probable until consummated, and therefore, stock-based compensation related to these RSUs remained unrecognized prior to the effectiveness of the IPO. Upon the effectiveness of the IPO in September 2020, the performance-based vesting condition was satisfied, and therefore, the Company recognized cumulative stock-based compensation of $55.5 million using the accelerated attribution method for the portion of the RSU awards for which the service-based vesting condition has been fully or partially satisfied. RSUs granted after the IPO do not contain the performance-based vesting condition described above, and the related stock-based compensation is recognized on a straight-line basis over the requisite service period. RSU activity during the nine months ended October 31, 2021 was as follows: Number of Shares Weighted-Average Grant Date Unvested Balance—January 31, 2021 9,348,557 $ 125.06 Granted 2,413,881 $ 223.93 Vested (531,845) $ 40.02 Forfeited (112,600) $ 134.52 Unvested Balance—April 30, 2021 11,117,993 $ 150.50 Granted 584,752 $ 244.05 Vested (820,002) $ 78.84 Forfeited (119,507) $ 169.75 Unvested Balance—July 31, 2021 10,763,236 $ 160.83 Granted 561,159 $ 305.15 Vested (980,901) $ 99.49 Forfeited (227,541) $ 180.53 Unvested Balance—October 31, 2021 10,115,953 $ 174.34 Stock-Based Compensation — The following table summarizes the weighted-average assumptions used in estimating the fair value of stock options granted to employees and non-employees during the three and nine months ended October 31, 2020: Three Months Ended Nine Months Ended October 31, 2020 October 31, 2020 Expected term (in years) 5.9 6.0 Expected volatility 38.4 % 37.2 % Risk-free interest rate 0.4 % 1.0 % Expected dividend yield — % — % No stock options were granted during the nine months ended October 31, 2021. Expected term —For stock options considered to be “plain vanilla” options, the Company estimates the expected term based on the simplified method, which is essentially the weighted average of the vesting period and contractual term, as the Company’s historical option exercise experience does not provide a reasonable basis upon which to estimate the expected term. Expected volatility —The Company performs an analysis of using the average volatility of a peer group of representative public companies with sufficient trading history over the expected term to develop an expected volatility assumption. Risk-free interest rate —Risk-free rate is estimated based upon quoted market yields for the United States Treasury debt securities for a term consistent with the expected life of the awards in effect at the time of grant. Expected dividend yield —Because the Company has never paid and has no intention to pay cash dividends on common stock, the expected dividend yield is zero. Fair value of underlying common stock —Prior to the completion of the IPO, the board of directors considered numerous objective and subjective factors to determine the fair value of the Company’s common stock at each meeting in which awards were approved. The factors considered included, but were not limited to: (i) the results of contemporaneous independent third-party valuations of the Company’s common stock; (ii) the prices, rights, preferences, and privileges of the Company’s redeemable convertible preferred stock relative to those of its common stock; (iii) the lack of marketability of the Company’s common stock; (iv) actual operating and financial results; (v) current business conditions and projections; (vi) the likelihood of achieving a liquidity event, such as an initial public offering or sale of the Company, given prevailing market conditions; and (vii) precedent transactions involving the Company’s shares. Since the completion of the IPO, the fair value of the Company’s common stock is determined by the closing price, on the date of grant, of its common stock, which is traded on the New York Stock Exchange. The following table summarizes the assumptions used in estimating the fair value of employee stock purchase rights granted under the 2020 ESPP during the three and nine months ended October 31, 2021 and 2020: Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 Expected term (in years) 0.5 0.5 0.5 0.5 Expected volatility 37.3 % 60.1 % 37.3% - 49.5% 60.1 % Risk-free interest rate 0.1 % 0.1 % 0.1 % 0.1 % Expected dividend yield — % — % — % — % Stock-based compensation included in the condensed consolidated statements of operations was as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 Cost of revenue $ 21,163 $ 13,226 $ 66,380 $ 15,507 Sales and marketing 43,074 39,481 141,463 49,714 Research and development 56,142 39,368 174,788 49,186 General and administrative 24,008 27,066 76,761 43,383 Stock-based compensation, net of amounts capitalized 144,387 119,141 459,392 157,790 Capitalized stock-based compensation 6,085 284 19,322 1,020 Total stock-based compensation $ 150,472 $ 119,425 $ 478,714 $ 158,810 As of October 31, 2021, total compensation cost related to unvested stock-based awards not yet recognized was $1.5 billion, which will be recognized over a weighted-average period of 3.1 years.

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company computes its tax provision for interim periods by applying the estimated annual effective tax rate to year-to-date pre-tax income from recurring operations and adjusting for discrete tax items arising in that quarter. The Company had an effective tax rate of (0.8%) and (0.3%) for the three and nine months ended October 31, 2021, respectively, and (0.3%) and (0.2%) for the three and nine months ended October 31, 2020, respectively. The Company has incurred U.S. operating losses and has minimal profits in foreign jurisdictions. The Company has evaluated all available evidence, both positive and negative, including historical levels of income and expectations and risks associated with estimates of future taxable income, and has determined that it is more likely than not that its net deferred tax assets will not be realized in the United States and the United Kingdom. Due to uncertainties surrounding the realization of the deferred tax assets, the Company maintains a full valuation allowance against its net deferred tax assets. The Company is subject to income taxes in the United States and numerous foreign jurisdictions. As of October 31, 2021, tax years 2012 and forward generally remain open for examination for U.S. federal and state tax purposes, and tax years 2017 and forward generally remain open for examination for foreign tax purposes. The Company has applied ASC 740 and determined that it has uncertain tax positions giving rise to unrecognized tax benefits for each of the three and nine months ended October 31, 2021 and 2020. The Company’s policy is to recognize interest and penalties related to uncertain tax positions in income tax expense. The Company does not anticipate any significant changes to unrecognized tax benefits over the next 12 months. None of the unrecognized tax benefits are currently expected to impact the Company’s effective tax rate, if realized, as a result of the full valuation allowance.

Net Loss per Share

Net Loss per Share	9 Months Ended
	Oct. 31, 2021
Earnings Per Share [Abstract]
Net Loss per Share	Net Loss per Share Basic and diluted net loss per share attributable to common stockholders is computed in conformity with the two-class method required for participating securities. Prior to the automatic conversion of all of its redeemable convertible preferred stock outstanding into Class B common stock upon the completion of the IPO, the Company considered all series of its redeemable convertible preferred stock and unvested common stock to be participating securities as the holders of such stock have the right to receive nonforfeitable dividends on a pari passu basis in the event that a dividend is declared on common stock. Under the two-class method, net loss is not allocated to the redeemable convertible preferred stock as the preferred stockholders do not have a contractual obligation to share in the Company’s losses. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by giving effect to all potentially dilutive common stock equivalents to the extent they are dilutive. For purposes of this calculation, redeemable convertible preferred stock, stock options, restricted stock awards, RSUs, employee stock purchase rights under the 2020 ESPP, early exercised stock options, and common stock warrants are considered to be common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is anti-dilutive for all periods presented. The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, converting, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted net loss per share attributable to common stockholders are, therefore, the same for both Class A and Class B common stock on both individual and combined basis. As discussed above in Note 11, on March 1, 2021, all 169,538,568 shares of the Company's then-outstanding Class B common stock, par value $0.0001 per share, were automatically converted into the same number of shares of Class A common stock, par value $0.0001 per share, pursuant to the terms of the Company’s amended and restated certificate of incorporation. No additional shares of Class B common stock will be issued following such conversion. In addition, on March 3, 2021, the Company filed a certificate with the Secretary of State of the State of Delaware effecting the retirement of the shares of Class B common stock that were issued but no longer outstanding following the conversion. The following table presents the calculation of basic and diluted net loss per share (in thousands, except share and per share data): Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 Numerator: Net loss attributable to Class A and Class B common stockholders $ (154,856) $ (168,889) $ (547,795) $ (340,167) Denominator: Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders – basic and diluted 303,006,685 166,868,200 297,435,637 93,763,599 Net loss per share attributable to Class A and Class B common stockholders – basic and diluted $ (0.51) $ (1.01) $ (1.84) $ (3.63) The following potentially dilutive securities were excluded from the computation of diluted net loss per share calculations for the periods presented because the impact of including them would have been anti-dilutive: October 31, 2021 2020 Stock options 47,781,688 69,634,367 Shares subject to repurchase 537,188 1,171,124 RSUs 10,115,953 7,616,097 Employee stock purchase rights under the 2020 ESPP 40,039 85,922 Total 58,474,868 78,507,510

Geographic Information

Geographic Information	9 Months Ended
	Oct. 31, 2021
Segment Reporting [Abstract]
Geographic Information	Geographic Information Revenue by geographic area, based on the location of the Company’s customers, was as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 United States $ 265,605 $ 135,427 $ 669,172 $ 341,892 Other (1) 68,836 24,197 166,381 59,692 Total $ 334,441 $ 159,624 $ 835,553 $ 401,584 ________________ (1) No other individual country accounted for more than 10% of the Company’s revenue for all periods presented. Long-lived assets, comprising property and equipment, net and operating lease right-of-use assets, by geographic area were as follows (in thousands): October 31, 2021 January 31, 2021 United States $ 268,546 $ 247,457 Other 9,888 8,329 Total $ 278,434 $ 255,786

Subsequent Events

Subsequent Events	9 Months Ended
	Oct. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsIn November 2021, certain non-marketable equity security investees of the Company raised additional funding in orderly transactions. As a result of these observable transactions, and absent any impairment or further adjustments under the Measurement Alternative that may arise, the Company expects to recognize aggregate non-cash gains of approximately $20 million on these investees’ non-marketable equity securities during the three months ended January 31, 2022.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2021
Accounting Policies [Abstract]
Fiscal Year	Fiscal Year The Company’s fiscal year ends on January 31. For example, references to fiscal 2022 refer to the fiscal year ending January 31, 2022.
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and applicable rules and regulations of the U.S. Securities and Exchange Commission (SEC) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2021, which was filed with the SEC on March 31, 2021.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of Snowflake Inc. and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
Segment Information	Segment InformationThe Company has a single operating and reportable segment. The Company’s chief operating decision maker is its Chief Executive Officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance, and allocating resources.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such estimates include, but are not limited to, stand-alone selling prices (SSP) for each distinct performance obligation, internal-use software development costs, expected period of benefit for deferred commissions, the useful lives of long-lived assets, the carrying value of operating lease right-of-use assets, the valuation of the Company’s common stock prior to its initial public offering (IPO) in September 2020, stock-based compensation, accounting for income taxes, and the fair value of investments in marketable and non-marketable securities. The Company bases its estimates on historical experience and also on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates due to risks and uncertainties, including uncertainty in the current economic environment due to the COVID-19 pandemic.
Accounts Receivable	Accounts ReceivableAccounts receivable includes billed and unbilled receivables, net of allowance for credit losses. Trade accounts receivable are recorded at invoiced amounts and do not bear interest. The allowance for credit losses is estimated based on the Company’s assessment of the collectibility of accounts receivable by considering various factors, including the age of each outstanding invoice, the collection history of each customer, historical write-off experience, current economic conditions, and reasonable and supportable forecasts of future economic conditions over the life of the receivable. The Company assesses collectibility by reviewing accounts receivable on an aggregate basis when similar characteristics exist and on an individual basis when specific customers with collectibility issues are identified. Accounts receivable deemed uncollectible are charged against the allowance for credit losses when identified.
Investments and Strategic Investments	Investments The Company’s investments in marketable debt securities have been classified and accounted for as available-for-sale and are recorded at estimated fair value. The Company classifies its marketable debt securities as either short-term or long-term at each balance sheet date based on each instrument’s underlying contractual maturity date. Short-term investments are investments with original maturities of less than one year when purchased. For available-for-sale debt securities in an unrealized loss position, the Company first assesses whether it intends to sell or it is more likely than not that the Company will be required to sell the security before the recovery of its entire amortized cost basis. If either of these criteria is met, the security’s amortized cost basis is written down to fair value through other income (expense), net in the condensed consolidated statements of operations. If neither of these criteria is met, the Company further assesses whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. Credit related unrealized losses are recognized as an allowance on the condensed consolidated balance sheets with a corresponding charge in the other income (expense), net in the condensed consolidated statements of operations. Non-credit related unrealized losses and unrealized gains on available-for-sale debt securities are included in accumulated other comprehensive income (loss). Realized gains and losses are determined based on the specific identification method and are reported in other income (expense), net in the condensed consolidated statements of operations. Strategic Investments The Company’s strategic investments consist of non-marketable equity and debt securities in privately-held companies and marketable equity securities in publicly-traded companies, in each case in which the Company does not have a controlling interest or significant influence. Strategic investments are included in other assets on the condensed consolidated balance sheets. The Company’s non-marketable equity securities are recorded at cost and adjusted for observable transactions for the same or similar investments of the same issuer (referred to as the Measurement Alternative) or impairment. For these investments, the Company recognizes remeasurement adjustments, including upward and downward adjustments, and impairments, if any, in other income (expense), net in the condensed consolidated statements of operations. Valuations of privately-held securities are inherently complex due to the lack of readily available market data and require the use of judgment. For example, determining whether an orderly transaction is for an identical or similar investment requires judgment based on the rights and obligations that attached to the securities. In determining the estimated fair value of these investments, the Company uses the most recent data available to the Company. Marketable equity securities are measured at fair value with changes in fair value recorded in other income (expense), net in the condensed consolidated statements of operations. Non-marketable debt securities are classified as available-for-sale and are recorded at their estimated fair value with changes in fair value recorded through accumulated other comprehensive income (loss). Strategic investments are subject to periodic impairment analyses, which involve an assessment of both qualitative and quantitative factors, including the investee’s financial metrics, market acceptance of the investee’s product or technology, and the rate at which the investee is using its cash. If the investment is considered impaired, the Company recognizes an impairment through other income (expense), net in the condensed consolidated statements of operations and establishes a new carrying value for the investment. The table above does not include the Company’s strategic investments in non-marketable equity securities, which are recorded at fair value on a non-recurring basis using the Measurement Alternative, or the Company's strategic investments in marketable equity securities and non-marketable debt securities, which are recorded at fair value on a recurring basis. The non-marketable equity and debt securities that the Company holds are valued using significant unobservable inputs or data in an inactive market. As a result, the Company classifies these assets as Level 3 within the fair value hierarchy. The estimation of fair value for the Company’s non-marketable equity securities requires the use of an observable transaction price and other unobservable inputs, including the volatility, rights, and obligations of the securities the Company holds. The marketable equity securities that the Company holds are valued using the quoted market price and are classified as Level 1 within the fair value hierarchy.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , which requires a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected, with further clarifications made more recently. For trade receivables, loans, and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses, which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are required to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. This guidance is effective for the Company for its fiscal year beginning February 1, 2023 and interim periods within that fiscal year, and requires a cumulative effect adjustment to the balance sheet as of the beginning of the first reporting period in which the guidance is effective. Early adoption is permitted. The Company early adopted this guidance effective February 1, 2021 on a modified retrospective basis, and the adoption did not result in any cumulative effect adjustment in its condensed consolidated financial statements. In August 2018, the FASB issued ASU No. 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract , which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this new guidance. This new guidance is effective for the Company for its fiscal year beginning February 1, 2021 and interim periods within its fiscal year beginning February 1, 2022, and early adoption is permitted. The Company adopted this guidance effective February 1, 2021 on a prospective basis, and the adoption did not have a material impact on its condensed consolidated financial statements . In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes by eliminating some exceptions to the general approach in ASC 740, Income Taxes (ASC 740) in order to reduce the cost and complexity of its application. This new guidance is effective for the Company for its fiscal year beginning February 1, 2022 and interim periods within its fiscal year beginning February 1, 2023, and early adoption is permitted. Most amendments within this guidance are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company early adopted this guidance effective February 1, 2021, and the adoption did not have a material impact on its condensed consolidated financial statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers , as if it had originated the contracts. Under the current business combinations guidance, such assets and liabilities are recognized by the acquirer at fair value on the acquisition date. This new guidance is effective for the Company for its fiscal year beginning February 1, 2023 and interim periods within that fiscal year, and early adoption is permitted. The Company early adopted this guidance upon issuance to all business combinations that occur on or after the date of adoption. The adoption had no impact on the Company’s condensed consolidated financial statements as there were no acquisitions accounted for as business combinations in fiscal 2022.
Fair Value Measurements	Fair Value Measurements The Company accounts for certain of its financial assets at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows: Level 1 Inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. Level 2 Inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. Level 3 Inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.
Revenue Recognition	Remaining performance obligations (RPO) represent the amount of contracted future revenue that has not yet been recognized, including both deferred revenue and non-cancelable contracted amounts that will be invoiced and recognized as revenue in future periods. The Company’s RPO excludes performance obligations from on-demand arrangements as there are no minimum purchase commitments associated with these arrangements, and certain time and materials contracts that are billed in arrears.However, the amount and timing of revenue recognition are generally driven by customer consumption, which can extend beyond the original contract term in cases where customers are permitted to roll over unused capacity to future periods, generally upon the purchase of additional capacity at renewal.
Net Loss per Share	Net Loss per Share Basic and diluted net loss per share attributable to common stockholders is computed in conformity with the two-class method required for participating securities. Prior to the automatic conversion of all of its redeemable convertible preferred stock outstanding into Class B common stock upon the completion of the IPO, the Company considered all series of its redeemable convertible preferred stock and unvested common stock to be participating securities as the holders of such stock have the right to receive nonforfeitable dividends on a pari passu basis in the event that a dividend is declared on common stock. Under the two-class method, net loss is not allocated to the redeemable convertible preferred stock as the preferred stockholders do not have a contractual obligation to share in the Company’s losses. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by giving effect to all potentially dilutive common stock equivalents to the extent they are dilutive. For purposes of this calculation, redeemable convertible preferred stock, stock options, restricted stock awards, RSUs, employee stock purchase rights under the 2020 ESPP, early exercised stock options, and common stock warrants are considered to be common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is anti-dilutive for all periods presented. The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, converting, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted net loss per share attributable to common stockholders are, therefore, the same for both Class A and Class B common stock on both individual and combined basis. As discussed above in Note 11, on March 1, 2021, all 169,538,568 shares of the Company's then-outstanding Class B common stock, par value $0.0001 per share, were automatically converted into the same number of shares of Class A common stock, par value $0.0001 per share, pursuant to the terms of the Company’s amended and restated certificate of incorporation. No additional shares of Class B common stock will be issued following such conversion. In addition, on March 3, 2021, the Company filed a certificate with the Secretary of State of the State of Delaware effecting the retirement of the shares of Class B common stock that were issued but no longer outstanding following the conversion.

Cash Equivalents and Investme_2

Cash Equivalents and Investments (Tables)	9 Months Ended
	Oct. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Schedule of Cash Equivalents and Investments	The following is a summary of the Company’s cash equivalents, short-term investments, and long-term investments on the condensed consolidated balance sheets (in thousands): October 31, 2021 Amortized Gross Gross Estimated Cash equivalents: Money market funds $ 581,689 $ — $ — $ 581,689 U.S. government securities 60,000 — — 60,000 Commercial paper 46,992 1 — 46,993 Certificates of deposit 27,001 1 — 27,002 Corporate notes and bonds 6,193 1 (1) 6,193 Total cash equivalents 721,875 3 (1) 721,877 Investments: Corporate notes and bonds 2,512,863 192 (3,278) 2,509,777 Commercial paper 1,066,027 82 (131) 1,065,978 U.S. government and agency securities 391,632 25 (321) 391,336 Certificates of deposit 200,382 31 (33) 200,380 Total investments 4,170,904 330 (3,763) 4,167,471 Total cash equivalents and investments $ 4,892,779 $ 333 $ (3,764) $ 4,889,348 January 31, 2021 Amortized Gross Gross Estimated Cash equivalents: Money market funds $ 334,891 $ — $ — $ 334,891 Commercial paper 242,040 2 (5) 242,037 Corporate notes and bonds 58,969 3 (2) 58,970 U.S. government securities 23,700 — — 23,700 Certificates of deposit 23,500 3 — 23,503 Total cash equivalents 683,100 8 (7) 683,101 Investments: Corporate notes and bonds 2,287,006 628 (481) 2,287,153 U.S. government and agency securities 1,016,059 250 (46) 1,016,263 Commercial paper 711,389 85 (102) 711,372 Certificates of deposit 238,278 97 (1) 238,374 Total investments 4,252,732 1,060 (630) 4,253,162 Total cash equivalents and investments $ 4,935,832 $ 1,068 $ (637) $ 4,936,263
Schedule of Cash Equivalents and Investments	The following is a summary of the Company’s cash equivalents, short-term investments, and long-term investments on the condensed consolidated balance sheets (in thousands): October 31, 2021 Amortized Gross Gross Estimated Cash equivalents: Money market funds $ 581,689 $ — $ — $ 581,689 U.S. government securities 60,000 — — 60,000 Commercial paper 46,992 1 — 46,993 Certificates of deposit 27,001 1 — 27,002 Corporate notes and bonds 6,193 1 (1) 6,193 Total cash equivalents 721,875 3 (1) 721,877 Investments: Corporate notes and bonds 2,512,863 192 (3,278) 2,509,777 Commercial paper 1,066,027 82 (131) 1,065,978 U.S. government and agency securities 391,632 25 (321) 391,336 Certificates of deposit 200,382 31 (33) 200,380 Total investments 4,170,904 330 (3,763) 4,167,471 Total cash equivalents and investments $ 4,892,779 $ 333 $ (3,764) $ 4,889,348 January 31, 2021 Amortized Gross Gross Estimated Cash equivalents: Money market funds $ 334,891 $ — $ — $ 334,891 Commercial paper 242,040 2 (5) 242,037 Corporate notes and bonds 58,969 3 (2) 58,970 U.S. government securities 23,700 — — 23,700 Certificates of deposit 23,500 3 — 23,503 Total cash equivalents 683,100 8 (7) 683,101 Investments: Corporate notes and bonds 2,287,006 628 (481) 2,287,153 U.S. government and agency securities 1,016,059 250 (46) 1,016,263 Commercial paper 711,389 85 (102) 711,372 Certificates of deposit 238,278 97 (1) 238,374 Total investments 4,252,732 1,060 (630) 4,253,162 Total cash equivalents and investments $ 4,935,832 $ 1,068 $ (637) $ 4,936,263
Schedule of Available For Sale Securities Remaining Contractual Maturity	The estimated fair values of available-for-sale debt securities, by remaining contractual maturity, are as follows (in thousands): October 31, 2021 Estimated Due within 1 year $ 3,095,801 Due in 1 year to 3 years 1,211,858 Total $ 4,307,659
Schedule of Unrealized Loss on Investments	The following table shows the fair values and the gross unrealized losses of these securities, classified by the length of time that the securities have been in a continuous unrealized loss position, and aggregated by investment types, excluding those securities classified within cash and cash equivalents on the condensed consolidated balance sheets (in thousands): October 31, 2021 Less than 12 Months 12 Months or Greater Total Fair Value Gross Fair Value Gross Fair Value Gross Cash equivalents: Commercial paper $ 17,998 $ — $ — $ — $ 17,998 $ — Corporate notes and bonds 5,058 (1) — — 5,058 (1) Total cash equivalents 23,056 (1) — — 23,056 (1) Investments: Corporate notes and bonds 2,170,442 (3,278) — — 2,170,442 (3,278) Commercial paper 449,901 (131) — — 449,901 (131) U.S. government and agency securities 230,705 (321) — — 230,705 (321) Certificates of deposit 40,844 (33) — — 40,844 (33) Total investments 2,891,892 (3,763) — — 2,891,892 (3,763) Total cash equivalents and investments $ 2,914,948 $ (3,764) $ — $ — $ 2,914,948 $ (3,764)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 31, 2021
Fair Value Disclosures [Abstract]
Schedule of Fair Value Measurements	The following table presents the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis as of October 31, 2021 (in thousands): Level 1 Level 2 Total Cash equivalents: Money market funds $ 581,689 $ — $ 581,689 U.S. government securities — 60,000 60,000 Commercial paper — 46,993 46,993 Certificates of deposit — 27,002 27,002 Corporate notes and bonds — 6,193 6,193 Short-term investments: Corporate notes and bonds — 1,454,923 1,454,923 Commercial paper — 1,065,978 1,065,978 U.S. government and agency securities — 243,323 243,323 Certificates of deposit — 191,389 191,389 Long-term investments: Corporate notes and bonds — 1,054,854 1,054,854 U.S. government and agency securities — 148,013 148,013 Certificates of deposit — 8,991 8,991 Total $ 581,689 $ 4,307,659 $ 4,889,348 The following table presents the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis as of January 31, 2021 (in thousands): Level 1 Level 2 Total Cash equivalents: Money market funds $ 334,891 $ — $ 334,891 Commercial paper — 242,037 242,037 Corporate notes and bonds — 58,970 58,970 U.S. government securities — 23,700 23,700 Certificates of deposit — 23,503 23,503 Short-term investments: Corporate notes and bonds — 1,318,573 1,318,573 U.S. government and agency securities — 829,318 829,318 Commercial paper — 711,372 711,372 Certificates of deposit — 228,624 228,624 Long-term investments: Corporate notes and bonds — 968,580 968,580 U.S. government and agency securities — 186,945 186,945 Certificates of deposit — 9,750 9,750 Total $ 334,891 $ 4,601,372 $ 4,936,263 The following table presents the fair value hierarchy for the Company’s strategic investments measured at fair value as of October 31, 2021 (in thousands): Level 1 Level 3 Total Equity securities: Non-marketable equity securities $ — $ 101,951 $ 101,951 Marketable equity securities 20,455 — 20,455 Debt securities: Non-marketable debt securities — 2,250 2,250 Total strategic investments $ 20,455 $ 104,201 $ 124,656 The following table presents the fair value hierarchy for the Company’s strategic investments measured at fair value as of January 31, 2021 (in thousands): Level 1 Level 3 Total Non-marketable equity securities $ — $ 41,000 $ 41,000 Non-marketable debt securities — 500 500 Total strategic investments $ — $ 41,500 $ 41,500

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	9 Months Ended
	Oct. 31, 2021
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following (in thousands): October 31, 2021 January 31, 2021 Computers, equipment, and software $ 6,642 $ 3,817 Furniture and fixtures 8,051 6,627 Leasehold improvements 51,670 41,593 Capitalized internal-use software development costs 16,030 12,855 Construction in progress 31,736 16,030 Total property and equipment 114,129 80,922 Less: accumulated depreciation and amortization (1) (19,752) (11,954) Total property and equipment, net $ 94,377 $ 68,968 ________________ (1) Includes $8.6 million and $5.5 million of accumulated amortization related to capitalized internal-use software development costs as of October 31, 2021 and January 31, 2021, respectively.

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	9 Months Ended
	Oct. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Intangible assets, net consisted of the following (in thousands): October 31, 2021 January 31, 2021 Finite-lived intangible assets Assembled workforce $ 15,099 $ — Developed technology 11,332 11,332 Patents 8,174 7,948 Other 47 47 Total finite-lived intangible assets 34,652 19,327 Less: accumulated amortization (9,311) (3,662) Total finite-lived intangible assets, net 25,341 15,665 Infinite-lived intangible assets - trademarks 826 426 Total intangible assets, net $ 26,167 $ 16,091
Schedule of Future Amortization Expense	As of October 31, 2021, future amortization expense is expected to be as follows (in thousands): Amount Fiscal Year Ending January 31, Remainder of 2022 $ 1,922 2023 7,687 2024 7,687 2025 6,838 2026 1,207 Total $ 25,341

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	9 Months Ended
	Oct. 31, 2021
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): October 31, 2021 January 31, 2021 Accrued compensation $ 82,238 $ 62,451 Accrued third-party cloud infrastructure expenses 13,977 6,648 Employee contributions under employee stock purchase plan 11,252 22,068 Employee payroll tax withheld on employee stock transactions 10,222 1,340 Accrued professional services 8,199 6,628 Accrued taxes 6,850 4,498 Accrued purchases of property and equipment 2,550 6,718 Other 27,950 14,964 Total accrued expenses and other current liabilities $ 163,238 $ 125,315

Equity (Tables)

Equity (Tables)	9 Months Ended
	Oct. 31, 2021
Share-based Payment Arrangement [Abstract]
Schedule of Shares Reserved For Future Issuance	The Company had reserved shares of common stock for future issuance as follows: October 31, 2021 January 31, 2021 2012 Equity Incentive Plan: Options outstanding 47,781,688 64,574,656 Restricted stock units outstanding 5,034,800 7,520,474 2020 Equity Incentive Plan: Shares available for future grants 45,681,389 32,871,367 Restricted stock units outstanding 5,081,153 1,828,083 2020 Employee Stock Purchase Plan: Shares available for future grants 8,208,724 5,700,000 Total shares of common stock reserved for future issuance 111,787,754 112,494,580
Option Activity Rollforward	Stock option activity and activity regarding shares available for grant under the Plans during the nine months ended October 31, 2021 is as follows: Shares Number of Options Outstanding Weighted- Weighted-Average Remaining Contractual Life Aggregate Balance—January 31, 2021 32,871,367 64,574,656 $ 7.04 7.7 $ 17,138,896 Shares authorized 14,395,880 — Options exercised — (7,081,859) $ 5.82 Options canceled 608,303 (608,303) $ 4.70 RSUs granted (2,413,881) — RSUs forfeited 112,600 — Balance—April 30, 2021 45,574,269 56,884,494 $ 7.21 7.5 $ 12,763,483 Options exercised — (3,974,786) $ 6.15 Options canceled 659,620 (659,620) $ 8.51 RSUs granted (584,752) — RSUs forfeited 119,507 — Balance—July 31, 2021 45,768,644 52,250,088 $ 7.28 7.3 $ 13,503,560 Options exercised — (4,222,037) $ 5.85 Options canceled 246,363 (246,363) $ 8.56 RSUs granted (561,159) — RSUs forfeited 227,541 — Balance—October 31, 2021 45,681,389 47,781,688 $ 7.40 7.1 $ 16,553,557 Vested and exercisable as of October 31, 2021 24,561,457 $ 6.24 6.7 $ 8,537,609
Option Rollforward Schedule	Stock option activity and activity regarding shares available for grant under the Plans during the nine months ended October 31, 2021 is as follows: Shares Number of Options Outstanding Weighted- Weighted-Average Remaining Contractual Life Aggregate Balance—January 31, 2021 32,871,367 64,574,656 $ 7.04 7.7 $ 17,138,896 Shares authorized 14,395,880 — Options exercised — (7,081,859) $ 5.82 Options canceled 608,303 (608,303) $ 4.70 RSUs granted (2,413,881) — RSUs forfeited 112,600 — Balance—April 30, 2021 45,574,269 56,884,494 $ 7.21 7.5 $ 12,763,483 Options exercised — (3,974,786) $ 6.15 Options canceled 659,620 (659,620) $ 8.51 RSUs granted (584,752) — RSUs forfeited 119,507 — Balance—July 31, 2021 45,768,644 52,250,088 $ 7.28 7.3 $ 13,503,560 Options exercised — (4,222,037) $ 5.85 Options canceled 246,363 (246,363) $ 8.56 RSUs granted (561,159) — RSUs forfeited 227,541 — Balance—October 31, 2021 45,681,389 47,781,688 $ 7.40 7.1 $ 16,553,557 Vested and exercisable as of October 31, 2021 24,561,457 $ 6.24 6.7 $ 8,537,609
Schedule of Unvested RSA Rollforward	Restricted Stock Awards —Restricted stock award activity during the nine months ended October 31, 2021 is as follows: Out of the Plans Number of Shares Weighted-Average Grant Date Unvested Balance—January 31, 2021 741,911 $ 2.11 Vested (90,412) $ 2.10 Unvested Balance—April 30, 2021 651,499 $ 2.11 Vested (90,414) $ 2.10 Unvested Balance—July 31, 2021 561,085 $ 2.11 Vested (90,412) $ 2.10 Unvested Balance—October 31, 2021 470,673 $ 2.11
Schedule of Unvested RSU Rollforward	RSU activity during the nine months ended October 31, 2021 was as follows: Number of Shares Weighted-Average Grant Date Unvested Balance—January 31, 2021 9,348,557 $ 125.06 Granted 2,413,881 $ 223.93 Vested (531,845) $ 40.02 Forfeited (112,600) $ 134.52 Unvested Balance—April 30, 2021 11,117,993 $ 150.50 Granted 584,752 $ 244.05 Vested (820,002) $ 78.84 Forfeited (119,507) $ 169.75 Unvested Balance—July 31, 2021 10,763,236 $ 160.83 Granted 561,159 $ 305.15 Vested (980,901) $ 99.49 Forfeited (227,541) $ 180.53 Unvested Balance—October 31, 2021 10,115,953 $ 174.34
Valuation Assumptions Schedule	The following table summarizes the weighted-average assumptions used in estimating the fair value of stock options granted to employees and non-employees during the three and nine months ended October 31, 2020: Three Months Ended Nine Months Ended October 31, 2020 October 31, 2020 Expected term (in years) 5.9 6.0 Expected volatility 38.4 % 37.2 % Risk-free interest rate 0.4 % 1.0 % Expected dividend yield — % — %
Valuation Assumptions Other Than Stock Options Schedule	The following table summarizes the assumptions used in estimating the fair value of employee stock purchase rights granted under the 2020 ESPP during the three and nine months ended October 31, 2021 and 2020: Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 Expected term (in years) 0.5 0.5 0.5 0.5 Expected volatility 37.3 % 60.1 % 37.3% - 49.5% 60.1 % Risk-free interest rate 0.1 % 0.1 % 0.1 % 0.1 % Expected dividend yield — % — % — % — %
Share-based Compensation Schedule	Stock-based compensation included in the condensed consolidated statements of operations was as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 Cost of revenue $ 21,163 $ 13,226 $ 66,380 $ 15,507 Sales and marketing 43,074 39,481 141,463 49,714 Research and development 56,142 39,368 174,788 49,186 General and administrative 24,008 27,066 76,761 43,383 Stock-based compensation, net of amounts capitalized 144,387 119,141 459,392 157,790 Capitalized stock-based compensation 6,085 284 19,322 1,020 Total stock-based compensation $ 150,472 $ 119,425 $ 478,714 $ 158,810

Net Loss per Share (Tables)

Net Loss per Share (Tables)	9 Months Ended
	Oct. 31, 2021
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Loss per Share	The following table presents the calculation of basic and diluted net loss per share (in thousands, except share and per share data): Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 Numerator: Net loss attributable to Class A and Class B common stockholders $ (154,856) $ (168,889) $ (547,795) $ (340,167) Denominator: Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders – basic and diluted 303,006,685 166,868,200 297,435,637 93,763,599 Net loss per share attributable to Class A and Class B common stockholders – basic and diluted $ (0.51) $ (1.01) $ (1.84) $ (3.63)
Schedule of Potentially Dilutive Securities Excluded from Computation of Net Loss per Share	The following potentially dilutive securities were excluded from the computation of diluted net loss per share calculations for the periods presented because the impact of including them would have been anti-dilutive: October 31, 2021 2020 Stock options 47,781,688 69,634,367 Shares subject to repurchase 537,188 1,171,124 RSUs 10,115,953 7,616,097 Employee stock purchase rights under the 2020 ESPP 40,039 85,922 Total 58,474,868 78,507,510

Geographic Information (Tables)

Geographic Information (Tables)	9 Months Ended
	Oct. 31, 2021
Segment Reporting [Abstract]
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas	Revenue by geographic area, based on the location of the Company’s customers, was as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 United States $ 265,605 $ 135,427 $ 669,172 $ 341,892 Other (1) 68,836 24,197 166,381 59,692 Total $ 334,441 $ 159,624 $ 835,553 $ 401,584 ________________ (1) No other individual country accounted for more than 10% of the Company’s revenue for all periods presented. Long-lived assets, comprising property and equipment, net and operating lease right-of-use assets, by geographic area were as follows (in thousands): October 31, 2021 January 31, 2021 United States $ 268,546 $ 247,457 Other 9,888 8,329 Total $ 278,434 $ 255,786

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	Oct. 31, 2021	Jan. 31, 2021
Accounting Policies [Abstract]
Allowance for credit losses	$ 0.9	$ 2.6

Cash Equivalents and Investme_3

Cash Equivalents and Investments - Schedule of Cash and Cash Equivalents and Investments Fair Value (Details) - USD ($) $ in Thousands	Oct. 31, 2021	Jan. 31, 2021
Cash equivalents:
Amortized Cost	$ 721,875	$ 683,100
Gross Unrealized Gains	3	8
Gross Unrealized Losses	(1)	(7)
Estimated Fair Value	721,877	683,101
Investments:
Amortized Cost	4,170,904	4,252,732
Gross Unrealized Gains	330	1,060
Gross Unrealized Losses	(3,763)	(630)
Debt securities	4,167,471	4,253,162
Amortized Cost	4,892,779	4,935,832
Gross Unrealized Gains	333	1,068
Gross Unrealized Losses	(3,764)	(637)
Estimated Fair Value	4,889,348	4,936,263
Corporate notes and bonds
Investments:
Amortized Cost	2,512,863	2,287,006
Gross Unrealized Gains	192	628
Gross Unrealized Losses	(3,278)	(481)
Debt securities	2,509,777	2,287,153
Commercial paper
Investments:
Amortized Cost	1,066,027	711,389
Gross Unrealized Gains	82	85
Gross Unrealized Losses	(131)	(102)
Debt securities	1,065,978	711,372
U.S. government and agency securities
Investments:
Amortized Cost	391,632	1,016,059
Gross Unrealized Gains	25	250
Gross Unrealized Losses	(321)	(46)
Debt securities	391,336	1,016,263
Certificates of deposit
Investments:
Amortized Cost	200,382	238,278
Gross Unrealized Gains	31	97
Gross Unrealized Losses	(33)	(1)
Debt securities	200,380	238,374
Money market funds
Cash equivalents:
Amortized Cost	581,689	334,891
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	581,689	334,891
U.S. government and agency securities
Cash equivalents:
Amortized Cost	60,000	23,700
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	60,000	23,700
Commercial paper
Cash equivalents:
Amortized Cost	46,992	242,040
Gross Unrealized Gains	1	2
Gross Unrealized Losses	0	(5)
Estimated Fair Value	46,993	242,037
Certificates of deposit
Cash equivalents:
Amortized Cost	27,001	23,500
Gross Unrealized Gains	1	3
Gross Unrealized Losses	0	0
Estimated Fair Value	27,002	23,503
Corporate notes and bonds
Cash equivalents:
Amortized Cost	6,193	58,969
Gross Unrealized Gains	1	3
Gross Unrealized Losses	(1)	(2)
Estimated Fair Value	$ 6,193	$ 58,970

Cash Equivalents and Investme_4

Cash Equivalents and Investments - Narrative (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2021	Jan. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Contractual maturities of available-for-sale debt securities, maximum	36 months
Gross unrealized losses on available-for-sale debt securities	$ 3,764	$ 637

Cash Equivalents and Investme_5

Cash Equivalents and Investments - Available for Sale Securities Remaining Contractual Maturity (Details) $ in Thousands	Oct. 31, 2021USD ($)
Investments, Debt and Equity Securities [Abstract]
Due within 1 year	$ 3,095,801
Due in 1 year to 3 years	1,211,858
Total	$ 4,307,659

Cash Equivalents and Investme_6

Cash Equivalents and Investments - Investments With Gross Unrealized Loss Positions (Details) $ in Thousands	Oct. 31, 2021USD ($)
Cash Equivalents, Fair Value
Less than 12 months, fair value	$ 23,056
12 months or greater, fair value	0
Total, fair value	23,056
Cash Equivalents, Gross Unrealized Losses
Less than 12 months, accumulated losses	(1)
12 months or greater, accumulated losses	0
Total, accumulated losses	(1)
Investments, Fair Value
Less than 12 months, fair value	2,891,892
12 months or greater, fair value	0
Total, fair value	2,891,892
Investments, Gross Unrealized Losses
Less than 12 months, accumulated losses	(3,763)
12 months or greater, accumulated losses	0
Total, accumulated losses	(3,763)
Cash Equivalents And Debt Securities, Available-For-Sale [Abstract]
Less than 12 months, fair value	2,914,948
12 months or greater, fair value	0
Total, fair value	2,914,948
Cash Equivalents And Debt Securities, Available-For-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Less than 12 months, accumulated losses	(3,764)
12 months or greater, accumulated losses	0
Total, accumulated losses	(3,764)
Commercial paper
Cash Equivalents, Fair Value
Less than 12 months, fair value	17,998
12 months or greater, fair value	0
Total, fair value	17,998
Cash Equivalents, Gross Unrealized Losses
Less than 12 months, accumulated losses	0
12 months or greater, accumulated losses	0
Total, accumulated losses	0
Investments, Fair Value
Less than 12 months, fair value	449,901
12 months or greater, fair value	0
Total, fair value	449,901
Investments, Gross Unrealized Losses
Less than 12 months, accumulated losses	(131)
12 months or greater, accumulated losses	0
Total, accumulated losses	(131)
Corporate notes and bonds
Cash Equivalents, Fair Value
Less than 12 months, fair value	5,058
12 months or greater, fair value	0
Total, fair value	5,058
Cash Equivalents, Gross Unrealized Losses
Less than 12 months, accumulated losses	(1)
12 months or greater, accumulated losses	0
Total, accumulated losses	(1)
Investments, Fair Value
Less than 12 months, fair value	2,170,442
12 months or greater, fair value	0
Total, fair value	2,170,442
Investments, Gross Unrealized Losses
Less than 12 months, accumulated losses	(3,278)
12 months or greater, accumulated losses	0
Total, accumulated losses	(3,278)
U.S. government and agency securities
Investments, Fair Value
Less than 12 months, fair value	230,705
12 months or greater, fair value	0
Total, fair value	230,705
Investments, Gross Unrealized Losses
Less than 12 months, accumulated losses	(321)
12 months or greater, accumulated losses	0
Total, accumulated losses	(321)
Certificates of deposit
Investments, Fair Value
Less than 12 months, fair value	40,844
12 months or greater, fair value	0
Total, fair value	40,844
Investments, Gross Unrealized Losses
Less than 12 months, accumulated losses	(33)
12 months or greater, accumulated losses	0
Total, accumulated losses	$ (33)

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Fair Value Measurements (Details) - USD ($) $ in Thousands	Oct. 31, 2021	Jan. 31, 2021
Assets, Fair Value Disclosure
Cash equivalents	$ 721,877	$ 683,101
Short-term investments	2,955,613	3,087,887
Long-term investments	1,211,858	1,165,275
Money market funds
Assets, Fair Value Disclosure
Cash equivalents	581,689	334,891
U.S. government and agency securities
Assets, Fair Value Disclosure
Cash equivalents	60,000	23,700
Commercial paper
Assets, Fair Value Disclosure
Cash equivalents	46,993	242,037
Certificates of deposit
Assets, Fair Value Disclosure
Cash equivalents	27,002	23,503
Corporate notes and bonds
Assets, Fair Value Disclosure
Cash equivalents	6,193	58,970
Recurring
Assets, Fair Value Disclosure
Total	4,889,348	4,936,263
Recurring | Corporate notes and bonds
Assets, Fair Value Disclosure
Short-term investments	1,454,923	1,318,573
Long-term investments	1,054,854	968,580
Recurring | Commercial paper
Assets, Fair Value Disclosure
Short-term investments	1,065,978	711,372
Recurring | U.S. government and agency securities
Assets, Fair Value Disclosure
Cash equivalents		23,700
Short-term investments	243,323	829,318
Long-term investments	148,013	186,945
Recurring | Certificates of deposit
Assets, Fair Value Disclosure
Short-term investments	191,389	228,624
Long-term investments	8,991	9,750
Recurring | Money market funds
Assets, Fair Value Disclosure
Cash equivalents	581,689	334,891
Recurring | U.S. government and agency securities
Assets, Fair Value Disclosure
Cash equivalents	60,000
Recurring | Commercial paper
Assets, Fair Value Disclosure
Cash equivalents	46,993	242,037
Recurring | Certificates of deposit
Assets, Fair Value Disclosure
Cash equivalents	27,002	23,503
Recurring | Corporate notes and bonds
Assets, Fair Value Disclosure
Cash equivalents	6,193	58,970
Recurring | Level 1
Assets, Fair Value Disclosure
Total	581,689	334,891
Recurring | Level 1 | Corporate notes and bonds
Assets, Fair Value Disclosure
Short-term investments	0	0
Long-term investments	0	0
Recurring | Level 1 | Commercial paper
Assets, Fair Value Disclosure
Short-term investments	0	0
Recurring | Level 1 | U.S. government and agency securities
Assets, Fair Value Disclosure
Cash equivalents		0
Short-term investments	0	0
Long-term investments	0	0
Recurring | Level 1 | Certificates of deposit
Assets, Fair Value Disclosure
Short-term investments	0	0
Long-term investments	0	0
Recurring | Level 1 | Money market funds
Assets, Fair Value Disclosure
Cash equivalents	581,689	334,891
Recurring | Level 1 | U.S. government and agency securities
Assets, Fair Value Disclosure
Cash equivalents	0
Recurring | Level 1 | Commercial paper
Assets, Fair Value Disclosure
Cash equivalents	0	0
Recurring | Level 1 | Certificates of deposit
Assets, Fair Value Disclosure
Cash equivalents	0	0
Recurring | Level 1 | Corporate notes and bonds
Assets, Fair Value Disclosure
Cash equivalents	0	0
Recurring | Level 2
Assets, Fair Value Disclosure
Total	4,307,659	4,601,372
Recurring | Level 2 | Corporate notes and bonds
Assets, Fair Value Disclosure
Short-term investments	1,454,923	1,318,573
Long-term investments	1,054,854	968,580
Recurring | Level 2 | Commercial paper
Assets, Fair Value Disclosure
Short-term investments	1,065,978	711,372
Recurring | Level 2 | U.S. government and agency securities
Assets, Fair Value Disclosure
Cash equivalents		23,700
Short-term investments	243,323	829,318
Long-term investments	148,013	186,945
Recurring | Level 2 | Certificates of deposit
Assets, Fair Value Disclosure
Short-term investments	191,389	228,624
Long-term investments	8,991	9,750
Recurring | Level 2 | Money market funds
Assets, Fair Value Disclosure
Cash equivalents	0	0
Recurring | Level 2 | U.S. government and agency securities
Assets, Fair Value Disclosure
Cash equivalents	60,000
Recurring | Level 2 | Commercial paper
Assets, Fair Value Disclosure
Cash equivalents	46,993	242,037
Recurring | Level 2 | Certificates of deposit
Assets, Fair Value Disclosure
Cash equivalents	27,002	23,503
Recurring | Level 2 | Corporate notes and bonds
Assets, Fair Value Disclosure
Cash equivalents	$ 6,193	$ 58,970

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Jul. 31, 2021	Oct. 31, 2021
Fair Value Disclosures [Abstract]
Cumulative amount of upward adjustments		$ 8.1
Annual amount of upward adjustments		$ 8.1
Strategic investment	$ 20		$ 20
Unrealized gain on investments	$ 0.5		$ 0.5

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Strategic Investments (Details) - USD ($) $ in Thousands	Oct. 31, 2021	Jan. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total strategic investments	$ 124,656	$ 41,500
Nonrecurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable equity securities	101,951	41,000
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable equity securities	20,455
Non-marketable debt securities	2,250	500
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total strategic investments	20,455	0
Level 1 | Nonrecurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable equity securities	0	0
Level 1 | Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable equity securities	20,455
Non-marketable debt securities	0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total strategic investments	104,201	41,500
Level 3 | Nonrecurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable equity securities	101,951	41,000
Level 3 | Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable equity securities	0
Non-marketable debt securities	$ 2,250	$ 500

Property and Equipment, Net - S

Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Oct. 31, 2021	Jan. 31, 2021
Property, Plant and Equipment
Total property and equipment	$ 114,129	$ 80,922
Less: accumulated depreciation and amortization	(19,752)	(11,954)
Total property and equipment, net	94,377	68,968
Computers, equipment, and software
Property, Plant and Equipment
Total property and equipment	6,642	3,817
Furniture and fixtures
Property, Plant and Equipment
Total property and equipment	8,051	6,627
Leasehold improvements
Property, Plant and Equipment
Total property and equipment	51,670	41,593
Capitalized internal-use software development costs
Property, Plant and Equipment
Total property and equipment	16,030	12,855
Less: accumulated depreciation and amortization	(8,600)	(5,500)
Construction in progress
Property, Plant and Equipment
Total property and equipment	$ 31,736	$ 16,030

Property and Equipment, Net - N

Property and Equipment, Net - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Property, Plant and Equipment [Abstract]
Depreciation	$ 3.6	$ 2	$ 9.9	$ 4.8

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2021	Jan. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	$ 34,652	$ 19,327
Less: accumulated amortization	(9,311)	(3,662)
Total finite-lived intangible assets, net	25,341	15,665
Infinite-lived intangible assets - trademarks	826	426
Intangible assets, net	26,167	16,091
Assembled workforce
Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	15,099	0
Developed technology
Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	11,332	11,332
Patents
Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	8,174	7,948
Other
Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	$ 47	$ 47

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020	Jan. 31, 2021
Business Acquisition [Line Items]
Indefinite-lived intangible assets acquired			$ 400,000
Amortization expense	$ 1,900,000	$ 900,000	5,700,000	$ 1,900,000
Goodwill	8,449,000		8,449,000		$ 8,449,000
Goodwill impairments	$ 0	$ 0	0	$ 0
Assembled workforce
Business Acquisition [Line Items]
Intangible assets acquired			$ 15,100,000
Weighted-average useful life			4 years
Patents
Business Acquisition [Line Items]
Weighted-average useful life			4 years
Indefinite-lived intangible assets acquired			$ 200,000

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Oct. 31, 2021	Jan. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2022	$ 1,922
2023	7,687
2024	7,687
2025	6,838
2026	1,207
Total finite-lived intangible assets, net	$ 25,341	$ 15,665

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2021	Jan. 31, 2021
Payables and Accruals [Abstract]
Accrued compensation	$ 82,238	$ 62,451
Accrued third-party cloud infrastructure expenses	13,977	6,648
Employee contributions under employee stock purchase plan	11,252	22,068
Employee payroll tax withheld on employee stock transactions	10,222	1,340
Accrued professional services	8,199	6,628
Accrued taxes	6,850	4,498
Accrued purchases of property and equipment	2,550	6,718
Other	27,950	14,964
Total accrued expenses and other current liabilities	$ 163,238	$ 125,315

Deferred Revenue and Remainin_2

Deferred Revenue and Remaining Performance Obligations - Deferred Revenue (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Revenue from Contract with Customer [Abstract]
Revenue recognized	$ 255	$ 121.2	$ 464	$ 222

Deferred Revenue and Remainin_3

Deferred Revenue and Remaining Performance Obligations - Remaining Performance Obligations (Details) $ in Billions	9 Months Ended
	Oct. 31, 2021USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	$ 1.8
Contracts With Original Terms Exceeding One Year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage	75.00%
Weighted-average remaining life	2 years 4 months 24 days

Commitment and Contingencies (D

Commitment and Contingencies (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Sublease income	$ 3,400,000	$ 3,200,000	$ 9,800,000	$ 9,600,000
Cost of matching contributions	0	$ 0	0	$ 0
Letters of credit outstanding	$ 17,000,000		$ 17,000,000

Redeemable Convertible Prefer_2

Redeemable Convertible Preferred Stock (Details) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended	9 Months Ended
	Sep. 30, 2020USD ($)shares	Oct. 31, 2020USD ($)$ / sharesshares	Oct. 31, 2020USD ($)$ / sharesshares	Oct. 31, 2021shares	Jul. 31, 2021shares	Jan. 31, 2021shares	Jul. 31, 2020shares	Jan. 31, 2020shares
Temporary Equity [Line Items]
Issuance of redeemable convertible preferred stock (in shares)			12,349,827
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)		182,271,099	182,271,099
Conversion of redeemable convertible preferred stock to common stock upon initial public offering | $		$ 1,415,047	$ 1,415,047
Reclassification of converted shares | $		$ 1,415,047	$ 1,415,047
Redeemable convertible preferred stock, shares outstanding (in shares)		0	0	0	0	0	182,271,099	169,921,272
Redeemable convertible preferred stock, shares issued (in shares)				0		0
Series G-1 Redeemable Convertible Preferred Stock
Temporary Equity [Line Items]
Issuance of redeemable convertible preferred stock (in shares)			8,480,857
Redemption price (in dollars per share) | $ / shares		$ 38.77	$ 38.77
Series G-2 Redeemable Convertible Preferred Stock
Temporary Equity [Line Items]
Issuance of redeemable convertible preferred stock (in shares)			3,868,970
Redemption price (in dollars per share) | $ / shares		$ 38.77	$ 38.77
Redeemable Convertible Preferred Stock
Temporary Equity [Line Items]
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)	182,271,099
Reclassification of converted shares | $	$ 1,400,000
Class B Common Stock
Temporary Equity [Line Items]
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)	182,271,099
Conversion ratio	1
Conversion of redeemable convertible preferred stock to common stock upon initial public offering | $	$ 1,400,000

Equity - Narrative (Details)

Equity - Narrative (Details) $ / shares in Units, $ in Thousands	Mar. 03, 2021shares	Mar. 01, 2021vote$ / sharesshares	Feb. 28, 2021vote	Feb. 28, 2020	Sep. 30, 2020USD ($)shares	Mar. 31, 2020shares	Mar. 31, 2019USD ($)shares	Dec. 31, 2017$ / sharesshares	Jun. 30, 2020USD ($)	Oct. 31, 2021USD ($)class$ / sharesshares	Jul. 31, 2021shares	Apr. 30, 2021shares	Oct. 31, 2020USD ($)	Oct. 31, 2021USD ($)class$ / sharesshares	Oct. 31, 2020USD ($)$ / shares	Apr. 30, 2020USD ($)	Jan. 31, 2021USD ($)$ / sharesshares	Feb. 29, 2020$ / shares
Share-based Compensation Arrangement by Share-based Payment Award
Preferred stock, shares authorized (in shares)										200,000,000				200,000,000			200,000,000
Preferred stock, par value (in dollars per share) | $ / shares										$ 0.0001				$ 0.0001			$ 0.0001
Common stock, number of classes of stock | class										2				2
Conversion, percent threshold				10.00%
Common stock reserved for future issuances (shares)										111,787,754				111,787,754			112,494,580
Options granted (shares)														0
Granted (in dollars per share) | $ / shares															$ 22.67
Intrinsic value of shares exercised | $														$ 3,800,000	$ 544,500
Grant date fair value of vested shares | $														62,700	71,000
Proceeds from repayments of a nonrecourse promissory note | $														0	2,090
Share-based compensation | $										$ 144,387			$ 119,141	$ 459,392	157,790
Shares subject to repurchase (in shares)										66,515				66,515			245,633
Liabilities for common stock subject to repurchase | $										$ 500				$ 500			$ 1,200
Compensation modification cost | $															$ 2,700	$ 16,700
Unrecognized share-based compensation expense | $										$ 1,500,000				$ 1,500,000
Unrecognized share-based compensation expense recognition period (term)														3 years 1 month 6 days
Employee stock purchase rights under the 2020 ESPP
Share-based Compensation Arrangement by Share-based Payment Award
Common stock reserved for future issuances (shares)										8,208,724				8,208,724			5,700,000
Stock market discount														85.00%
Offering period														6 months
Stock options
Share-based Compensation Arrangement by Share-based Payment Award
Vesting period (years)														4 years
Expiration period (years)														10 years
RSUs
Share-based Compensation Arrangement by Share-based Payment Award
Vesting period (years)														4 years
Unvested shares (shares)										10,115,953	10,763,236	11,117,993		10,115,953			9,348,557
Vested (shares)										980,901	820,002	531,845
Share-based compensation | $					$ 55,500
2020 Plan | RSUs
Share-based Compensation Arrangement by Share-based Payment Award
Common stock reserved for future issuances (shares)										5,081,153				5,081,153			1,828,083
2012 Plan | Stock options
Share-based Compensation Arrangement by Share-based Payment Award
Common stock reserved for future issuances (shares)										47,781,688				47,781,688			64,574,656
Expiration period (years)														10 years
2012 Plan | RSUs
Share-based Compensation Arrangement by Share-based Payment Award
Common stock reserved for future issuances (shares)										5,034,800				5,034,800			7,520,474
Out of the Plans | RSA
Share-based Compensation Arrangement by Share-based Payment Award
Unvested shares (shares)										470,673	561,085	651,499		470,673			741,911
Vested (shares)										90,412	90,414	90,412
Out of the Plans | RSA | Privately-Held Company
Share-based Compensation Arrangement by Share-based Payment Award
Unvested shares (shares)										158,173				158,173
Issuance of common stock in connection with an acquisition (in shares)							661,635
Vested (shares)							215,031
Share-based compensation | $							$ 1,100
Vesting period (years)							4 years
Out of the Plans | RSA | Privately-Held Company | Share-based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award
Vesting period (years)							4 years
Out of the Plans | RSA | Promissory Notes
Share-based Compensation Arrangement by Share-based Payment Award
Vesting period (years)								5 years
Shares authorized (shares)								1,250,000
Shares issued (in dollars per share) | $ / shares								$ 1.59
Debt instrument, stated interest rate								2.11%
Proceeds from repayments of a nonrecourse promissory note | $									$ 2,100
Unvested shares (shares)										312,500				312,500
Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award
Common stock, shares authorized (in shares)					2,500,000,000					2,500,000,000				2,500,000,000			2,500,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001								$ 0.0001				$ 0.0001			$ 0.0001
Common stock, voting rights, votes per share | vote		1
Class A Common Stock | Employee stock purchase rights under the 2020 ESPP
Share-based Compensation Arrangement by Share-based Payment Award
Common stock reserved for future issuances (shares)					5,700,000
Class A Common Stock | 2020 Plan
Share-based Compensation Arrangement by Share-based Payment Award
Common stock reserved for future issuances (shares)					34,100,000
Maximum common shares authorized to be outstanding (shares)					78,816,888
Class B Common Stock
Share-based Compensation Arrangement by Share-based Payment Award
Common stock, shares authorized (in shares)					355,000,000					185,461,432				185,461,432			355,000,000
Shares converted (in shares)	169,538,568	169,538,568
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001								$ 0.0001				$ 0.0001			$ 0.0001
Common stock, voting rights, votes per share | vote			10
Shares issued (in dollars per share) | $ / shares																		$ 38.77
Shares issued for common stock (shares)						8,600,000

Equity - Shares Reserved For Fu

Equity - Shares Reserved For Future Issuance (Details) - shares	Oct. 31, 2021	Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award
Common stock reserved for future issuances (shares)	111,787,754	112,494,580
Employee stock purchase rights under the 2020 ESPP
Share-based Compensation Arrangement by Share-based Payment Award
Common stock reserved for future issuances (shares)	8,208,724	5,700,000
2012 Plan | Stock options
Share-based Compensation Arrangement by Share-based Payment Award
Common stock reserved for future issuances (shares)	47,781,688	64,574,656
2012 Plan | RSUs
Share-based Compensation Arrangement by Share-based Payment Award
Common stock reserved for future issuances (shares)	5,034,800	7,520,474
2020 Plan | RSUs
Share-based Compensation Arrangement by Share-based Payment Award
Common stock reserved for future issuances (shares)	5,081,153	1,828,083
2020 Plan | Shares available for future grants
Share-based Compensation Arrangement by Share-based Payment Award
Common stock reserved for future issuances (shares)	45,681,389	32,871,367

Equity - Stock Option Activity

Equity - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended			9 Months Ended	12 Months Ended
	Oct. 31, 2021	Jul. 31, 2021	Apr. 30, 2021	Oct. 31, 2021	Jan. 31, 2021
Shares Available for Grant
Shares available for grant, beginning (in shares)	45,768,644	45,574,269	32,871,367	32,871,367
Shares authorized (in shares)			14,395,880
Options canceled (in shares)	246,363	659,620	608,303
Shares available for grant, ending (in shares)	45,681,389	45,768,644	45,574,269	45,681,389	32,871,367
Number of Options Outstanding
Shares outstanding, beginning (in shares)	52,250,088	56,884,494	64,574,656	64,574,656
Options exercised (in shares)	(4,222,037)	(3,974,786)	(7,081,859)
Options canceled (in shares)	(246,363)	(659,620)	(608,303)
Shares outstanding, ending (in shares)	47,781,688	52,250,088	56,884,494	47,781,688	64,574,656
Weighted- Average Exercise  Price
Shares outstanding, beginning balance (in dollars per share)	$ 7.28	$ 7.21	$ 7.04	$ 7.04
Options exercised (in dollars per share)	5.85	6.15	5.82
Options canceled (in dollars per share)	8.56	8.51	4.70
Shares outstanding, ending balance (in dollars per share)	$ 7.40	$ 7.28	$ 7.21	$ 7.40	$ 7.04
Weighted-average remaining contractual life	7 years 1 month 6 days	7 years 3 months 18 days	7 years 6 months		7 years 8 months 12 days
Aggregate Intrinsic Value (in thousands)
Aggregate intrinsic value	$ 16,553,557	$ 13,503,560	$ 12,763,483	$ 16,553,557	$ 17,138,896
Vested and exercisable (in shares)	24,561,457			24,561,457
Vested and exercisable, weighted average share price (in dollars per share)	$ 6.24			$ 6.24
Vested and exercisable, weighted average remaining contractual life				6 years 8 months 12 days
Vested and exercisable, aggregate intrinsic value	$ 8,537,609			$ 8,537,609
RSUs
Shares Available for Grant
RSU's granted (in shares)	(561,159)	(584,752)	(2,413,881)
RSU's forfeited (in shares)	227,541	119,507	112,600

Equity - Unvested RSA & RSU Rol

Equity - Unvested RSA & RSU Rollforward (Details) - $ / shares	3 Months Ended
	Oct. 31, 2021	Jul. 31, 2021	Apr. 30, 2021
RSA | Out of the Plans
Number of Shares
Unvested balance, beginning (shares)	561,085	651,499	741,911
Vested (shares)	(90,412)	(90,414)	(90,412)
Unvested balance, ending (shares)	470,673	561,085	651,499
Weighted-Average Grant Date Fair Value per Share
Unvested balance , beginning balance (per share)	$ 2.11	$ 2.11	$ 2.11
Vested (per share)	2.10	2.10	2.10
Unvested balance , ending balance (per share)	$ 2.11	$ 2.11	$ 2.11
RSUs
Number of Shares
Unvested balance, beginning (shares)	10,763,236	11,117,993	9,348,557
Granted (shares)	561,159	584,752	2,413,881
Vested (shares)	(980,901)	(820,002)	(531,845)
Forfeited (shares)	(227,541)	(119,507)	(112,600)
Unvested balance, ending (shares)	10,115,953	10,763,236	11,117,993
Weighted-Average Grant Date Fair Value per Share
Unvested balance , beginning balance (per share)	$ 160.83	$ 150.50	$ 125.06
Granted (per share)	305.15	244.05	223.93
Vested (per share)	99.49	78.84	40.02
Forfeited (per share)	180.53	169.75	134.52
Unvested balance , ending balance (per share)	$ 174.34	$ 160.83	$ 150.50

Equity - Valuation Assumptions

Equity - Valuation Assumptions (Details)	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Stock options
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology
Expected term (in years)		5 years 10 months 24 days		6 years
Expected volatility		38.40%		37.20%
Risk-free interest rate		0.40%		1.00%
Expected dividend yield		0.00%		0.00%
Employee stock purchase rights under the 2020 ESPP
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology
Expected term (in years)	6 months	6 months	6 months	6 months
Expected volatility			37.30%
Expected volatility			49.50%
Expected volatility	37.30%	60.10%		60.10%
Risk-free interest rate	0.10%	0.10%	0.10%	0.10%
Expected dividend yield	0.00%	0.00%	0.00%	0.00%

Equity - Share-based Compensati

Equity - Share-based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Stock-based compensation, net of amounts capitalized	$ 144,387	$ 119,141	$ 459,392	$ 157,790
Capitalized stock-based compensation	6,085	284	19,322	1,020
Total stock-based compensation	150,472	119,425	478,714	158,810
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Stock-based compensation, net of amounts capitalized	21,163	13,226	66,380	15,507
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Stock-based compensation, net of amounts capitalized	43,074	39,481	141,463	49,714
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Stock-based compensation, net of amounts capitalized	56,142	39,368	174,788	49,186
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Stock-based compensation, net of amounts capitalized	$ 24,008	$ 27,066	$ 76,761	$ 43,383

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Income Tax Disclosure [Abstract]
Effective tax rate	(0.80%)	(0.30%)	(0.30%)	(0.20%)

Net Loss per Share - Narrative

Net Loss per Share - Narrative (Details) - $ / shares	Mar. 03, 2021	Mar. 01, 2021	Oct. 31, 2021	Jan. 31, 2021
Class B Common Stock
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Shares converted (in shares)	169,538,568	169,538,568
Common stock, par value (in dollars per share)		$ 0.0001	$ 0.0001	$ 0.0001
Class A Common Stock
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Common stock, par value (in dollars per share)		$ 0.0001	$ 0.0001	$ 0.0001

Net Loss per Share - Schedule o

Net Loss per Share - Schedule of Basic and Diluted Net Loss per Share (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Earnings Per Share [Abstract]
Net loss attributable to Class A and Class B common stockholders		$ (154,856)	$ (168,889)	$ (547,795)	$ (340,167)
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders - basic (in shares)	[1]	303,006,685	166,868,200	297,435,637	93,763,599
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders - diluted (in shares)	[1]	303,006,685	166,868,200	297,435,637	93,763,599
Net loss per share attributable to Class A and Class B common stockholders - basic (in dollars per share)	[1]	$ (0.51)	$ (1.01)	$ (1.84)	$ (3.63)
Net loss per share attributable to Class A and Class B common stockholders - diluted (in dollars per share)	[1]	$ (0.51)	$ (1.01)	$ (1.84)	$ (3.63)
[1]	On March 1, 2021, all shares of the Company’s then-outstanding Class B common stock were automatically converted into the same number of shares of Class A common stock, pursuant to the terms of the Company’s amended and restated certificate of incorporation. No additional shares of Class B common stock will be issued following such conversion. See Note 11 for further details.

Net Loss per Share - Schedule_2

Net Loss per Share - Schedule of Potentially Dilutive Securities Excluded from Computation of Net Loss per Share (Details) - shares	9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from computation of diluted net loss per share (in shares)	58,474,868	78,507,510
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from computation of diluted net loss per share (in shares)	47,781,688	69,634,367
Shares subject to repurchase
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from computation of diluted net loss per share (in shares)	537,188	1,171,124
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from computation of diluted net loss per share (in shares)	10,115,953	7,616,097
Employee stock purchase rights under the 2020 ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from computation of diluted net loss per share (in shares)	40,039	85,922

Geographic Information - Revenu

Geographic Information - Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Revenues from External Customers and Long-Lived Assets
Revenue	$ 334,441	$ 159,624	$ 835,553	$ 401,584
United States
Revenues from External Customers and Long-Lived Assets
Revenue	265,605	135,427	669,172	341,892
Other
Revenues from External Customers and Long-Lived Assets
Revenue	$ 68,836	$ 24,197	$ 166,381	$ 59,692

Geographic Information - Long-l

Geographic Information - Long-lived Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2021	Jan. 31, 2021
Revenues from External Customers and Long-Lived Assets
Non-current assets	$ 278,434	$ 255,786
United States
Revenues from External Customers and Long-Lived Assets
Non-current assets	268,546	247,457
Other
Revenues from External Customers and Long-Lived Assets
Non-current assets	$ 9,888	$ 8,329

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ in Millions	3 Months Ended
	Jan. 31, 2022	Jul. 31, 2021
Subsequent Event [Line Items]
Gain on equity securities		$ 8.1
Forecast
Subsequent Event [Line Items]
Gain on equity securities	$ 20